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Introduction
In general a high morbidity is associated with ablative surgery for cancer 
in the head and neck. The aim of reconstructive surgery is restoration of 
function and form, thereby allowing aggressive oncological resections. 
Reconstructions in head and neck surgery are performed by tissue 
transfer. Local ﬂaps have been used extensively but are limited in their 
application. Microvascular free ﬂaps give the opportunity to transfer a 
wide variety of ﬂaps, which can be tailor-made to the missing tissue to be 
reconstructed. Almost every defect can thus be treated in one operation, 
using microvascular composite ﬂaps. One of the major challenges in 
head and neck reconstructive surgery is reconstruction of the mandible. 
Reconstructions with non-vascularised bone grafts have been used in the 
past mainly as secondary reconstructions. Primary reconstruction with 
free bone grafts is difﬁcult to achieve because of a high risk of infection 
and leads to a high failure rate. The non-vascularized bone has little 
resistance against bacterial invasion. Microsurgically revascularised bone 
ﬂaps have sufﬁcient vascularity, which produces higher success rates. 
Using microvascular ﬂaps, a revolution in reconstructive surgery has been 
established and this new and powerful method of reconstruction even 
makes reconstructions in radiated patients possible1.
Unfortunately, the inevitable consequence of these reconstructions is 
donor site morbidity. In contrast to the abundance of articles describing the 
advantages of vascularised bone ﬂap reconstructions, little attention has 
been paid to donor site morbidity. Our study of the literature on donor site 
morbidity in vascularised bone ﬂap surgery serves as the basis of this article, 
in which we will, 1) present a short introduction of free ﬂap surgery in head 
and neck reconstructions in general and in mandibular reconstruction in 
particular, 2) discuss speciﬁc ﬂaps for bone reconstruction, and 3) review 
the donor site morbidity of these bone ﬂaps. Further, we will take a look at 
the future when tissue engineering may minimize donor site morbidity by 
creating prefabricated free ﬂaps1.
1 15
Free ﬂap surgery in head and neck reconstructions
Shan R. Baker and William R. Panje at the University of Iowa College 
of Medicine performed the ﬁrst successful reconstruction of the 
oral cavity with a microsurgical skin ﬂap2. Since then a wealth of 
microvascular free ﬂaps has been used: myocutaneous, osteocutaneus, and 
osteomusculocutaneous ﬂaps as well as portions of the stomach, jejunum, 
and large bowel have been applied for a wide variety of defects in the head 
and neck region3, 4.
Oral cavity reconstruction
Defects of the oral cavity can be analyzed as to their component parts: 
deﬁcits of internal lining, loss of skeletal support (mandible or maxilla), and 
defects of external soft tissue or any combination of these5. For intra-oral 
lining the radial forearm ﬂap is the ﬂap of choice. This is a thin and pliable 
ﬂap, which is highly reliable. As an alternative, the lateral upper arm ﬂap is 
used6. By anastomosing the lateral cutaneous nerve, it is possible to provide 
sensation to the radial forearm ﬂap, used for oral reconstruction7, 8.
Hypopharyngeal reconstruction
The aim of hypopharyngeal reconstruction is to obtain a successful 
conduit and to allow swallowing. Hypopharyngeal reconstruction for 
partial circumferential defects can be achieved by a patch graft of the radial 
forearm ﬂap. In case of a complete circumferential defect, the hypopharynx 
can be reconstructed by a tubed radial forearm ﬂap9 or a free jejunal 
graft10. Fistula formation remains a common, but usually self-limiting, 
complication.
Skull base surgery
The resection of tumors of the infratemporal fossa extending to the skull 
base is now accessible by an intracranial-extracranial approach. Resection 
of these tumors often involves a sacriﬁce of the nasopharyngeal and 
paranasal sinus structures. The resultant defects place the cranial cavity 
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in communication with the oral cavity. An essential requirement of the 
reconstructive procedure in this situation is to ensure a reliable separation 
of these two areas to prevent meningitis. The creation of a functional 
separation of intracranial and extracranial cavities can be extremely 
difﬁcult to accomplish, especially when multiple cavities (nasal, oral, and 
pharyngeal) are violated. In select cases free ﬂaps provide a solution to this 
problem11, 12.
Facial palsy
Facial palsy can be a congenital13 or an acquired palsy of the mimic 
musculature. Many reconstruction methods have been used, ranging from 
static reconstructions with tendon slings where only symmetry at rest is 
obtained, to dynamic reconstructions with transposition or transplantation 
of functional muscle. Emphasis has been placed on the latter: dynamic 
reconstruction for restoration of active smiling14. For this purpose different 
functional free muscle transfers are used, like the latissimus dorsi15, the 
pectoralis minor16-18, the gracilis19, 20 and the rectus femoris21. 
Mandibular reconstruction
The goals of mandibular reconstruction are to reconstitute the mandibular 
arch and to allow for prosthetic restoration. Conventional bone-grafting 
techniques have been applied, but the widespread use of radiotherapy in 
head and neck cancer patients limits its usefulness. In vascularised bone 
reconstructions, healing by callus replaces the creeping substitution of 
conventional bone grafts22. In addition, the vascularity of the attached 
soft tissues promotes primary healing and decreases the chance of ﬁstula 
and sinus formation. When recipient beds are hostile due to irradiation, 
scarring, or chronic infection, these ﬂaps can survive and even improve 
the blood supply of the sites into which they are placed by their vascular 
independence. Large segments of bone can be transferred with the same 
success rate as smaller ones because of their autonomy. Furthermore, free 
osteocutaneous transfer is achieved in a single stage. This permits the 
patient to resume his or her regular social activities in the shortest possible 
time. The immediate restoration of appearance and function and absence of 
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long-term sequelae are particularly important in the older patient whose life 
span is limited because of age, general health, or the disease process itself. 
In these patients, preservation of the quality of life is paramount even if 
survival is barely improved. In case of younger patients, the reliability and 
durability of vascularised bone grafts and their ability to accomodate oral 
implants for oral rehabilitation make them the procedures of choice, even 
when the host bed is not hostile23.
Microvascular free ﬂaps can provide radiotherapy resistant reconstructions, 
while at the same time providing oral lining or external lining, or both. 
A variety of osteo (musculo-) cutaneous ﬂaps is applicable. The most often 
used are the iliac crest or deep circumﬂex iliac artery ﬂap, ﬁbula ﬂap, 
scapular ﬂap and radial forearm ﬂap (ﬁg. 1). The donor site morbidity of 
these free bone ﬂaps will be discussed.
Donor site morbidity in free bone ﬂaps
Radial forearm free ﬂap
Introduction
The radial forearm ﬂap was introduced in the English literature by Song 
in 198224 but originally developed in the Shenyang Military Hospital in 
China by Yang et al25, 26. This popular free ﬂap is based on the radial artery 
and its concomitant veins or subcutaneous forearm veins. It can be used 
as a fasciocutaneous ﬂap; vascularised tendons, nerves7, and bone27 may be 
included. Vascularised bone as a component of this ﬂap can be removed 
Figure 1. This is a combination of a osteocutaneous 
ﬁbular ﬂap and a fasciocutaneous radial forearm 
ﬂap to treat a large defect of the mandible 
and soft tissues. The ﬁbula has already been 
osteotomized in shape and linked to the radial 
forearm ﬂap. The donor defect is extensive.
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from the distal lateral portion of the radius extending from the insertion 
of the pronator teres tendon to the insertion of the brachioradialis tendon. 
This bone is supplied by perforating branches of the radial artery and 
venae comitantes by means of direct fascio-osseous perforators proximally 
and small perforators through the ﬂexor pollicis longus muscle distally. 
Approximately 10 to 12 cm of vascularised radius may be elevated in this 
fashion28. Usually a split skin graft26 or a full thickness graft29, 30 is used to 
close the resulting skin donor site defect. Speciﬁc donor site complications 
comprise: fracture of the radius, delayed wound healing, cold intolerance, 
neuroma formation of the superﬁcial radial nerve, impaired strength of the 
donor hand, and restricted wrist mobility. 
Delayed wound healing
The most frequent problem is delayed wound healing of the grafted donor 
site. This is observed in approximately 30 to 50 percent of cases31. Although 
most donor wounds eventually heal, this sometimes requires more than 
6 months. Especially in the group of patients with an osteocutaneous ﬂap 
this is a great problem32. After delayed healing, adhesions of skin to the 
ﬂexor tendons occur. To prevent these adhesions, the tendons can be buried 
under the adjacent ﬂexor muscle bellies33-35. In this way a better wound bed 
for skin grafting is obtained. Another solution is to prevent a skin graft by 
using tissue-expansion36, a pursestring closure37, or a skin stretching 
device38, 39. In small ﬂaps, the donor site may be closed by a pedicled ulnar 
forearm ﬂap32, 40; then no adhesions will occur32. To cover the osteotomized 
radius the pronator quadratus muscle with a split skin graft can be used41. 
Although the donor defect is visible and unsightly, only few patients 
complain about this cosmetic problem42.
Radial forearm ﬂap
In the forearm the radial artery and comitant veins supply perforating branches to the skin 
via the intermuscular septum. Other perforating branches that travel through the muscle 
belly of the ﬂexor pollicis longus muscle, supply vascularity to the radial bone. Due to this 
anatomy a ﬂap consisting of the skin, subcutis of the volar side of the forearm and part of 
the radial bone, can be transplanted to any part of the body, provided this pedicle, consisting 
of the radial artery and comitant veins is included. The pedicle can be anastomosed by 
microsurgical techniques to vessels in any part of the body. These so called ‘free ﬂaps’ give 
the reconstructive surgeon the opportunity to use distant tissue for reconstructions in 
difﬁcult area’s, e.g. radiated tissue.
i
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Cold intolerance
Cold intolerance can develop after accidental as well as surgical trauma to 
the hand. It has been described after replantation of digits and after repair 
of nerve injury43. The incidence of cold intolerance ranges from 0 to 27 
percent44. Little is known of the cause of this intolerance. One study in 
which ultrasound was used, reveals that there is no vascular basis42. Another 
retrospective study with thermography revealed that the width of the donor 
site inﬂuences the rewarming of the donor hand. This is probably due to a 
change in vasoregulation as a result of sympathetic nerve damage45.
Out of concern of postoperative hand ischemia46, the radial artery was 
routinely reconstructed by a vein graft in the past, but graft patency was a 
disappointing 50 percent. The unreconstructed cases showed no signs of 
alteration attributable to vascular insufﬁciency in function of the hand32. 
Therefore, routine reconstruction of the radial artery has been abandoned47.
Neuroma formation
Absence of pinprick sensation is a common ﬁnding in grafted donor 
sites and an early ﬁnding in transposition ﬂaps. Sensory recovery in 
transposition ﬂaps usually occurs.
After harvesting a radial forearm ﬂap, in a majority of the patients reduced 
sensation in the distribution of the superﬁcial radial nerve occurs. In time, 
sensation often returns48. When raising the ﬂap, the superﬁcial radial 
nerve is easily identiﬁed and should be preserved intact. The presence 
of hyperesthetic areas has been reported in 3 percent of the cases, while 
neuromata in branches of the superﬁcial radial nerve have been observed in 
2-10 percent of the patients32, 48.
Fracture of the radius and grip strength
Fracture of the radius is a serious complication of the composite (skin and 
bone) radial forearm ﬂap. Fracture can occur at any time during or after 
surgery, but usually within 6 weeks of operation (ﬁg. 2). Females are affected 
more than males, possibly because the radius is smaller and osteoporosis is 
more common in females. If the fracture is recognized immediately during 
the operation and treated properly, no loss of function will result. 
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Otherwise, loss of supination and of pinch power between the thumb and 
index ﬁnger will occur due to loss of ﬂexor pollicis longus function. Several 
measures can be taken to prevent fracture of the radius: removal of a smaller 
bone segment (about one third the circumference of the radius); use of a 
boat-shaped osteotomy to prevent overcutting, as can occur in a traditional 
right angled osteotomy; adequate immobilization for 6 to 8 weeks; or even 
prophylactic plating of the radius30, 38, 49. Soutar and McGregor have stated 
in early reports utilizing this osseocutaneous vascularised ﬂap in head and 
neck reconstruction that no more than 40 percent of the cross-sectional 
area of the radius should be removed in the clinical situation, stating that 
this should not jeopardize donor radius strength50. A one-third-thickness 
osteotomy results in a 76 percent decrease in breaking strength31. Despite 
limited bone removal, the current literature reports a donor site fracture rate 
of 8 to 43 percent26, 32, 48,50-52. 
Reduction in wrist mobility and grip strength are a complication of fracture 
of the radius. In a prospective study, small reductions in wrist mobility 
were noted in fasciocutaneous and composite no-fracture groups, but 
large reductions were noted in the composite fracture group. Reductions 
in ﬂexion (58 percent), extension (50 percent), pronation (31 percent), 
supination (31 percent), and adduction (55 percent) were found48. Still, 
even without a fracture of the radius, grip strength may be diminished. 
The cause for this lies in the harvest of the ﬂexor pollicis longus muscle in 
composite ﬂaps. This muscle is needed to ensure perfusion of the bone.
Surprisingly, few patients complain of symptoms relating to joint motion, 
and very few complain of any functional deﬁcit. In fasciocutaneous 
ﬂaps without bone harvesting, grip strength is 11.9 percent less than on 
the contralateral hand, but since the operated hand is usually the non-
Figure 2. A radiograph of a fracture of the 
radius. This patient underwent a mandibular 
reconstruction by an osteocutaneous radial 
forearm ﬂap. In the post operative period the 
patient fell, while riding horse-back.
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dominant hand, this is not clinically signiﬁcant42, 53. An unsuspected but 
signiﬁcant correlation was found between sensory defect of the radial nerve 
and weak grip strength in the operated hand. Reduction in circumference 
reﬂects muscle atrophy. Remarkably, when this was measured, reduction in 
circumference was found on the control arm as well as on the donor arm. 
This means that at least part of the atrophy is due to systemic factors, and 
not to raising of the ﬂap itself. In addition to this, Richardson reported 
more reduction in grip strength in the control arm than in the donor arm 
in composite ﬂaps. No explanation for this phenomenon could be found48. 
As it is clear that patients with a fracture of the radius develop serious 
impairment of hand function, some authors recommend not to use this 
osteo-cutaneous ﬂap anymore, and to use other donor sites.
Fibula free ﬂap
Introduction
In 1975 Ian Taylor described for the ﬁrst time the free vascularised ﬁbula 
ﬂap for reconstruction of the lower extremity54. Later, Hidalgo adapted this 
ﬂap for mandibular reconstruction55. Since then, it has become one of the 
most popular ﬂaps in mandibular reconstruction56. About 25 cm of bone 
can be harvested, while preserving 6 to 7 cm of bone both distally and 
proximally to maintain the integrity of the knee and ankle joints. The bone 
is perfused by segmental branches of the peroneal artery. A skin ﬂap can be 
included in the dissection, based on perforators from the peroneal artery57. 
A composite ﬂap can be obtained by including the soleus muscle or ﬂexor 
hallucis longus muscle58-60. The ﬁbula has numerous advantages to other 
bone ﬂaps in mandibular reconstruction; i.e. virtually no length limitations, 
consistent bone shape, adequate bone height for oral implants, segmental 
blood supply and a ﬂexible skin island. Most authors report a low rate of 
morbidity61, although when objectively measured, some authors do ﬁnd 
problems62. 
Fibula ﬂap
In the lower leg the peroneal artery and comitant veins supply perforating branches to the 
skin via the intermuscular septum. Other branches supply the ﬁbula. Just as with the radial 
forearm ﬂap, this ﬁbula ﬂap can be harvested as a free ﬂap consisting of bone and skin, 
provided the peroneal vessels are included as the pedicle.
i
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Delayed wound healing
Usually the donor site can be closed primarily, which leads to minor 
postoperative donor site morbidity: cellulitis and small wound break-
down63. If a skin graft is needed, more than 50 percent of the patients 
will experience delayed wound healing64 (ﬁg. 3). Still, if there is tension 
at the suture line, a skin graft can minimize the possibility of wound 
complications65.
Nerve damage
The peroneal nerve is the nerve at risk in using the ﬁbula ﬂap. This includes 
sensory and motor disturbances. Sensory disturbances can occur in 24 
percent of the cases63. Hypesthesia involves either the superﬁcial or deep 
peroneal nerve sensory distribution. Motor disturbances lead to weakness 
in dorsiﬂexion, which can occur in 7 percent of cases due to damage of 
peroneal nerve branches66. All these nerve deﬁcits were completely resolved 
within 3 months.
Ambulation 
Although changes in gait, paresis of the ﬂexors of the toes and hallux, and 
sensibility changes have been described, the majority of patients are able to 
ambulate normally. Some patients experience limitations with running. An 
average of 5.1 weeks after surgery, people are able to ambulate without pain, 
and only a minority reports mild occasional discomfort. Gait analysis shows 
only minimal joint motion effects in patients with follow-up times longer 
than 10 months, but muscle strengths are signiﬁcantly impaired, especially 
Figure 3. Delayed healing in a patient with a ﬁbular 
free ﬂap for a mandibular reconstruction. The 
donor site was skin grafted. The Achilles tendon 
is uncovered.
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foot inversion and eversion. An inverse relationship existed between the 
length of resected ﬁbula and muscle strength in ankle eversion67. The loss 
of the ﬁbula and the interosseus membrane, which form the origin of the 
deep muscles, leads to muscle disturbance with consequent loss of function. 
This loss of function is greater if a musculo-osteo-cutaneous ﬂap is used. 
Patients may complain of pain and inability to run. Pain and edema usually 
occur after prolonged standing or extensive ambulation. X-rays may reveal 
osteoporosis of the distal remnant of the ﬁbula, which is likely the result 
of the decrease in load transmission. Longer segments are less osteoporotic 
because there is more available interosseous membrane to connect and 
stabilize the ﬁbula to the tibia68. Occasional ankle instability and ankle 
stiffness is reported. Isokinetic testing reveals a signiﬁcant decrease in 
ankle mobility and a signiﬁcant decrease in strength during all four ankle 
motions. No decrease in knee mobility is seen, but there is a signiﬁcant 
decrease in strength during knee ﬂexion and extension. Almost all patients 
have limited ﬂexion capability of the hallux consistent with inclusion of 
the ﬂexor hallucis longus muscle with the ﬂap. This does not interfere 
with ambulation, however64. The most likely explanation for the apparent 
discrepancy between the actual measured decreases in leg joint range of 
motion and muscle strength and the patient’s perception is that the leg and 
ankle have a large physiologic reserve, which is only partially compromised 
by ﬁbula ﬂap harvest. Pre- and early post operative physiotherapy are 
recommended, emphasizing the maintenance of ankle range of motion. 
When the integrity of the ankle joint in adults is in doubt, ﬁxation of 
the distal ﬁbula just proximal to the syndesmosis by means of a screw is 
indicated69. In children distal tibio-ﬁbular arthrodesis is always advocated to 
avoid elevation of the lateral malleolus and valgus deformity of the ankle70.
Iliac crest free ﬂap
Introduction
The iliac crest ﬂap is based on the deep circumﬂex iliac vessels71, 72. These 
vessels originate from the external iliac vessels, after which they travel on 
the deep surface of the inguinal ligament, give off a branch to the internal 
oblique muscle, and then lie in the groove between the attachment of the 
iliac and transverse abdominal muscles. From here, perforators go through 
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the abdominal muscles to supply the skin. The deep circumﬂex iliac vessels 
anastomose posteriorly with branches from the lumbar vessels73, 74. This 
ﬂap can be harvested as bone only (bicortical or monocortical75), or in 
combination with skin and/or external oblique muscle76. The donor site 
of the skin can be closed primarily, which leaves a scar that can easily be 
hidden under the clothes23. Postoperatively, patients are encouraged to walk 
within the ﬁrst week, usually walking unassisted after 2 weeks. 
Nerve damage
Advantages of this large bone ﬂap are more highlighted than the donor site 
complications77, 78. If the lateral femoral nerve is transected, the sensation 
of the lateral side of the thigh is impaired79. Injury to the lateral cutaneous 
and ilioinguinal nerves can occur, and thigh pain and anesthesia are the 
unpleasant postoperative sequelae.
Contour and herniation
Removal of bicortical bone produces signiﬁcant donor site deformity (ﬁg. 
4) and asymmetry. Herniation of the abdomen is a risk, which can be 
worsened by denervation of the rectus muscle. Meticulous dissection of the 
nerves, which lie between the internal oblique and transverse abdominal 
muscles, can prevent this denervation80. Sometimes a mesh repair is 
necessary. Herniations occur from 323 to 9 percent81.
Figure 4. Left iliac crest was used as a donor site for 
mandibular reconstruction.
Iliac crest ﬂap
The iliac crest is another osteocutaneous free ﬂap, supplied by the Deep Circumﬂex Iliac 
Artery. The external iliac artery gives off this branch just above the inguinal canal. The DCIA 
runs at the inside of the pelvis, between the insertion of the iliac muscle and the origin of 
the internal oblique muscle of the abdominal wall at the iliac crest. An ascending branch of 
the DCIA supplies this internal oblique muscle. Multiple branches from the DCIA perforate 
the abdominal wall, just above the iliac crest, and supply the overlying skin. With this 
pedicle bone, muscle and skin can be harvested in one ﬂap.
i
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Ambulation
Commonly, one ﬁnds an initial weakness of the hip, resulting in an antalgic 
limp. Usually, but not always23, this resolves by 6 months. Sometimes a 
paresis of the femoral nerve occurs, with subsequent loss of knee extension, 
but in the majority of cases this is not permanent. In 5 percent of the 
patients, permanent loss is caused by either excessively vigorous retraction 
at the time of surgery or pressure from a tight closure23.
In conclusion, the iliac crest free ﬂap offers abundant bone and has the 
possibility of including skin and muscle. Some serious problems in walking 
can occur.
Scapular free ﬂap
Introduction
The subscapular system of ﬂaps depends on branches emanating from the 
vascular tree of the subscapular artery. Arising from the axillary artery, this 
vessel bifurcates in the circumﬂex scapular artery and the thoraco-dorsal 
artery. The circumﬂex scapular artery gives off an ascending, transverse, 
and descending branch. From the descending branch, multiple periosteal 
branches supply the lateral border of the scapula. The thoraco-dorsal artery 
bifurcates in the serratus anterior branch and in two muscular branches 
in the latissimus dorsi muscle, a lateral and a medial branch. The angular 
branch to the inferior pole of the scapula arises either just proximal to 
the serratus branch, or from the serratus branch itself. This independent 
nutrient vessel allows a second means of obtaining a vascularised scapular 
bone graft82. 
Scapula ﬂap
In the back the subscapular artery, a branch of the axillary artery, supplies part of the 
scapular bone, the latissimus dorsi and serratus anterior muscles and overlying skin. 
Combined ﬂaps can be harvested from this region and used for reconstructions in any part 
of the body.
i
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This vascular system gives the microsurgeon the opportunity to use 
multiple independent ﬂaps with just one common vascular source. 
Especially the generous latitude in the placement of the bone relative to 
the skin or muscle portions of the ﬂap is a clear advantage. The latissimus 
dorsi and serratus anterior muscles, together with the ascending scapular, 
scapular and parascapular fasciocutaneous ﬂaps, and a portion of the 
scapular bone can be used in a variety of combinations83. A bone graft up to 
14 cm can be obtained from the lateral border of the scapula.
Shoulder function
The weakness of the rotator cuff muscles resulting from division of the 
teres major and minor muscles in the lateral scapular ﬂap can be a serious 
disability when added to the shoulder dysfunction of an ipsilateral radical 
neck dissection. If possible, the ipsilateral scapular ﬂap donor site should be 
avoided if the 11th nerve is sacriﬁced in the neck dissection84. Two patients 
out of 26 developed restricted elevation of the arm, probably because of 
insufﬁcient cooperation in shoulder exercises85. Although patients consider 
their shoulder motion functionally adequate 6 months postoperatively, half 
of the patients have mild to moderate limitations of shoulder abduction 
and external rotation86. To prevent problems in shoulder function, vigorous 
postoperative physical therapy is necessary87, 88. To put these donor site 
problems in perspective, a Japanese questionnaire investigation did not 
ﬁnd any problems that would indicate that the lateral border of the scapula 
should not be used as a donor site89. Thoma describes a modiﬁcation of 
the scapular free ﬂap, in which he uses the medial part of the scapula. The 
method of harvesting the medial scapular ﬂap requires some rhomboid 
muscle dissection. The disability from this division was inconsequential in 
his patients’ postoperative shoulder dysfunction. The shoulder weakness 
which his patients experienced was attributed to the neck dissections. This 
reduction in donor site morbidity is a major advantage over the lateral 
scapular ﬂap which can impose signiﬁcant rotator cuff dysfunction.
Concluding, this versatile ﬂap is a very important one in modern reconstructive 
surgery. The donor site morbidity consists mainly of a mild impairment of 
shoulder function90, which may become important when an ipsilateral neck 
dissection with sacriﬁce of the eleventh cranial nerve has been carried out.
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Rationale
Considering the relative importance of donor site morbidity (Table 1), the 
most important complication of the radial forearm ﬂap is fracture of the 
radial bone, which can lead to serious loss of function. Partly because of 
this serious complication the radial forearm ﬂap is used less frequently for 
mandibular reconstruction. Currently, the ﬁbula ﬂap is the ﬂap most widely 
used for mandibular reconstruction. Although delayed wound healing 
is a frequent complication in this ﬂap91, it usually has no serious long 
term consequences. Gait however, seems to be a potentially more serious 
problem. Nevertheless, patients complain relatively infrequently about this, 
probably because of the large physiologic reserve people have. The iliac crest 
is less popular than the ﬁbula ﬂap in mandibular reconstruction., Patients 
frequently complain of the contour deformity, although this can be avoided 
if a monocortical ﬂap is used and a meticulous repair of the inguinal 
ligament is performed. The scapula ﬂap is used less frequently; despite the 
fact that it appears to have little donor site morbidity.
Although microsurgical techniques have made reconstructions possible, 
which three decades ago were considered impossible, the donor site 
morbidity inherent to these reconstructions is underexposed. Autografting 
(transplantation of bone from one site to another site in the same person) 
leaves the patient with inherent donor site morbidity. Another problem 
with the use of autogenic bone can be a mere lack of sufﬁcient bone tissue. 
ﬂap number freq. used (%) morbidity freq. complications (%)
radial forearm ﬂap 6 18 fracture 33
ﬁbula 22 65 delayed wound healing; gait 32; 9
iliac crest 5 15 gait 20
scapula 1 3 shoulder function 0
total 34 100
Table 1. Frequencies of use and complications of osteocutaneous ﬂaps (own experience 1992-2000)
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Therefore, other approaches have to be explored that can solve these 
problems. Evidently, allografts (transplantation of bone from a donor to 
a recipient of the same species) are not the solution, because this material 
shows a very high resorbtion rate. In addition, disease transmission (AIDS, 
HIV) from donor to recipient is possible and reported, even though the 
tissue undergoes extensive processing and testing92. The same is true 
for the use of pure synthetic materials as grafting material, like calcium 
phosphate ceramics and bioglass. Although these materials support the 
bone repair process, they do not actively inﬂuence the bone regeneration 
process. Another strategy to stimulate bone growth and to create bone graft 
substitutes (BGS) is the use of tissue engineering methods, either by use of 
bone morphogenic proteins with an appropriate carrier, or by the use of 
cultured cells with an appropriate carrier93, 94. In both methods, a suitable 
carrier material is needed, which until now, has not been deﬁned95, 96. 
Various studies have shown that CaP ceramics97, biodegradable polymeric 
materials98-101 (polylactic acid, polyglycolic acid) as well as metals102 can be 
used as scaffold material. Therefore, it can be suggested that developments 
for bone graft substitutes will proceed with as ﬁnal goal the manufacturing 
of engineered, preshaped, vascularised bone grafts. These preshaped, 
vascularised bone grafts can then be designed at a convenient donor site. 
New advancements in this process of tissue engineering can perhaps solve 
the current problems with donor site morbidity.
Objective and hypothesis
In view of the above, the objective of this thesis is to develop a method 
for microsurgical reconstruction of bone defects with the help of tissue 
engineering techniques. First, we will evaluate the usefulness of a non-
invasive technique in the evaluation of bone formation like Magnetic 
Resonance Imaging (MRI). Standardized invasive evaluation techniques 
like histology and histomorphometry are widely used for this purpose, but 
they have an important disadvantage: to avoid interanimal differences 
large numbers of experimental animals are necessary. MRI is a tool that 
can be used to evaluate bone formation in vivo. With this technique, less 
animals would be necessary in experiments. Demineralized Bone Matrix 
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(DBM), which consists of a scaffold with Bone Morphogenic Proteins will 
be used for our ﬁrst experiments and a comparison will be made to another 
non-invasive technique: Dual Energy X-ray Absorptiometry (DEXA). Also 
Magnetic Resonance Angiography (MRA) will be used to evaluate the blood 
ﬂow in the pedicle of the ﬂap.
Then, the next step is the induction of bone formation. In our strategy, 
bone marrow is the source for the bone forming cells, which are 
subsequently added to an appropriate carrier or scaffold material. The 
optimal carrier, as well as the optimal site for this bone forming process still 
has to be determined. One step further is to transplant this newly formed 
bone to the appropriate defect site, e.g. a segmental mandibular defect. 
This can be done by using the prefabricated ﬂap as a pedicled ﬂap or as a 
microsurgical free ﬂap.
In order to develop a method for microsurgical reconstruction of bone 
defects with the help of tissue engineering techniques, we will address the 
following questions. 
1.  Can MRI be used in a longitudinal study to noninvasively detect bone formation in a rat 
model and can it give quantitative as well as morphological information about the construct? 
2.  What is the best method for noninvasive monitoring of bone formation, MRI or DEXA? And 
can MRA be used to demonstrate the vascularity of the pedicle of a prefabricated ﬂap?
3.  What is the inﬂuence of the surface area of the carrier for the bone forming capacity?
4.  What is the most useful carrier for a cell-based construct, titanium ﬁbre mesh or a ceramic 
implant?
5.  What is the most useful acceptor site for a prefabricated ﬂap, muscle or subcutaneous tissue?
6. What is the inﬂuence of a microsurgical anastomosis of the vascular pedicle of a prefabricated 
muscle ﬂap on the tissue engineered bone in this ﬂap?
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Introduction
In reconstructive surgery donor site morbidity is a consequence of the use of 
free revascularized ﬂaps1. Tissue engineering is a promising new tool which 
could help to minimize this donor site morbidity. Since the pioneering 
work on ectopic bone formation by Urist 19652, animal models have been 
commonly and successfully used in the study of tissue engineering of  
bone3, 4. In animal research histology remains the gold standard for 
assessing bone formation. A disadvantage associated with this analysis 
method, is that longitudinal studies are difﬁcult to perform. For example, 
we know that the ﬁnal tissue or healing response can be affected by 
speciﬁc characteristics of an individual animal. To avoid such interanimal 
differences, longitudinal study designs have always to be based on large 
numbers of experimental animals. In view of this, other techniques have 
to be explored to study and follow wound healing phenomena in animals. 
Alternative methods for histology as already have been used in the past; 
include radiographs and Dual Energy X-ray Absorptiometry (DEXA). 
DEXA is based on the principle that X-rays pass through various body 
tissues with different attenuation. Therefore, they can be differentiated. By 
using X-rays at two different energy levels, better tissue differentiation is 
possible compared with single energy systems5. Although radiographs and 
DEXA measurements can provide some additional information, they still 
suffer from signiﬁcant disadvantages. For example, quantiﬁcation of bone 
formation with X-ray imaging is not possible. The DEXA technique is very 
well suited for the overall monitoring of bone behavior around implants6, 7. 
However, quantiﬁcation of the bone density in a narrow zone close to an 
implant is less predictable8. This makes DEXA inappropriate for determining 
the bone healing sequence in porous scaffolds, with pore sizes between  
100-300 µm, as frequently used in bone tissue engineering.
On the other hand, during the last decennium, large progress has been 
made with another diagnostic approach, i.e. Magnetic Resonance Imaging 
(MRI). Although MRI, just as DEXA scan, doesn’t have the same high 
resolution as histology, this imaging modality allows the three-dimensional 
visualization of body tissues. Diagnostic applications for this technology 
include the brain, chest, abdomen and skeletal system. Further, MRI is 
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used clinically in humans and in animal research. For this last application, 
separate equipment has been developed. Despite these developments and 
innovations, MRI is still not an accepted or well-documented technique to 
follow wound healing dealing with bone reconstruction.
In this report we explore the possibilities of using in vivo MRI methods for 
studying bone formation. Consequently, the objective of the present study 
was: to investigate whether it is possible to use MRI to demonstrate ectopic 
bone formation in the rat. This investigation was done by comparing MRI 
to the conventional techniques currently in use for demonstrating ectopic 
bone formation, i.e. soft X-ray images and histology. In this pilot study, 
histology was obtained after sacriﬁce only.
Materials and methods 
Implants
Demineralized bone matrix (DBM)
Two 10 week male Wistar (W.U.) donor rats were sacriﬁced by cervical 
dislocation. From the diaphysis of the resected femora, pieces with a length 
of 1 cm were cut and, after ﬂushing with saline to remove the bone marrow, 
immediately chilled to 0°C. The fragments were decalciﬁed in 0.6 N HCl 
(1g bone per 100 ml 0.6 N HCl) under constant stirring during 48 hours 
at a temperature of 2°C, the hydrochloric acid being changed after 24 hrs. 
After elution of the acid in 0.15 N NaCl, the fragments were lyophilized and 
stored at -20°C. The average weight of the DBM implants was 31.3 mg and 
the average diameter of the implants was 5 millimeter.
Inactivated demineralized bone matrix (iDBM)
Appropriate pieces of rat demineralized bone matrix were extracted for 24 
hrs. at 4°C with 4 M guanidine hydrochloride in 50mM TRIS-HCl, pH 7.4 (4 
pieces DBM in 10 ml), containing protease inhibitors (5 mM benzamidine 
hydrochloride, 5 mM N-ethylmaleimide, 100 mM 6-aminocaproic acid, and 
0.5 mM phenylmethylsulphonyl ﬂuoride). The insoluble rat organic matrix 
remaining after the 4M guanidine hydrochloride extraction was washed ﬁve 
times with an excess of demineralized water during 24 hrs, lyophilized and 
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stored at -20 °C. The average weight of the iDBM implants was 19.8 mg and 
the average diameter of the implants was 5 millimeter.
Experimental design and surgical procedure
Surgery
One male Wistar rat (W.U., 10 weeks of age, weight 280 grams) was 
anaesthetized using a mixture of ﬁfty percent oxygen with ﬁfty percent 
nitric oxide and 1.2% Isoﬂurane (Forene® (1-chloro-2,2,2-triﬂuorethyl-
diﬂuoromethyl-ether).
Four implants were placed subcutaneously in the back of the animal as 
schematically shown in Figure 1: two DBM (DBM_prox and DBM_dist) and 
two iDBM (iDBM_prox and iDBM_dist). At 1, 3, 5 and 7 weeks after surgery, 
soft X-ray images and MRI were obtained. After seven weeks, the animal 
was sacriﬁced using an overdose of diethyl ether anesthesia. Following 
euthanasia, the implants with their surrounding tissue were retrieved and 
prepared for histological and histomorphometrical evaluation.
Figure 1. Schematic illustration of the subcutaneous 
placement of the DBM implants. Two DBM 
implants (DBM_prox and DBM_dist) were placed 
on the left side, two iDBM implants (iDBM_prox 
and iDBM_dist) were placed at the right side.
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The implants were studied by MRI at weeks 1, 3, 5, and 7 post operatively. 
During the MRI investigation the rat was anesthetized with isoﬂurane  
(4% initially and 1.3% for maintenance) and a 1:1 (v/v) nitrous oxide and 
oxygen gas mixture. The animal was placed into the magnet in a supine 
position, on top of a 40 mm circular RF surface coil (Figure 2) covering 
all four implanted pieces of (i-)DBM. During the MRI experiments the 
respiration rate was continuously monitored and the core temperature was 
registered with a rectal probe and maintained with a variable-temperature 
circulating-water bed. Gradient-echo MRI experiments (TE = 6 ms; TR = 
1000 ms; ﬂip angle = 60°; ﬁeld of view = 55 mm; matrix size = 256 x 256 
data points) were carried out on an S.M.I.S. 7T/200mm horizontal-bore MR 
spectrometer equipped with a Magnex Scientiﬁc 150mT/m gradient set. 
With these experimental parameters, the MRI shows mainly proton-density 
weighting. T2* weighting, however, cannot be completely excluded since 
tissue T2* values are generally very short at the high magnetic ﬁeld strength 
used (7.0 Tesla). After a pilot scan to establish the orientation of the DBM 
implants, twenty parallel transverse slices (thickness 1.5 mm; separation 
2.0 mm) were acquired. As the length of the DBM implants is 10 mm, each 
DBM is visible in 5 contiguous slices. The total duration of the scanning was 
4.3 minutes.
X-ray images
Standardized whole body soft X-ray images were obtained at weeks 1, 
3, 5 and 7. A working distance of 30 cm, an exposure time of 0.8 sec 
and an accelerating voltage of 45 kV were used. At 7 weeks, the animal 
Figure 2. The rat is lying on his back 
in the MRI with his tail on the right. 
He is seen from the undersurface 
through a transparent plate. The four 
subcutaneous implants are located 
within the diameter of the 40 mm 
circular RF surface coil.
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was euthanized and all implants with surrounding tissue were retrieved. 
Subsequently, these specimens were ﬁxed and stored in phosphate-buffered 
4% formalin solution (pH = 7.4). Then, the tissue blocks were dehydrated 
in a graded series of ethanol and embedded in methyl-methacrylate. After 
polymerization, a ﬁnal soft X-ray image was made of all implants (6 cm; 
0.05 sec; 60 kV).
Light microscopic evaluation
After X-raying, the MMA embedded samples were prepared for histological 
analysis. Therefore, thin sections (thickness 10 mm) were made using a 
modiﬁed sawing microtome technique6. Transverse sections were made 
on 5 levels in each implant. These levels corresponded with the transverse 
slices of the MRI evaluation. The sections were stained with methylene 
blue and basic fuchsin. To evaluate the tissue response to the implants, 
both histological and histomorphometrical evaluation was performed. The 
histological evaluation consisted of a complete description of the observed 
thin sections.
Image analysis techniques were performed for the histomorphometrical 
analysis. We used a computer based image analysis system (Qwin Pro, 
Leica). The following parameters were assessed: (1) bone surface area and (2) 
DBM / iDBM area. All histomorphometrical measurements were performed 
in 5 different transverse sections per implant. Presented results are based on 
the average of these measurements.
Results
X-ray images
At week three none of the implants was visible on whole body soft X-ray 
images (Figure 3). At week 5 and 7 implant DBM_prox could clearly be seen. 
On the other hand, no evidence of bone formation was observed in the other 
DBM implant (DBM_dist) or in the two iDBM implants (iDBM_prox and 
iDBM_dist). In the post-explantation PMMA X-ray images implant DBM_prox 
was clearly detectable as well as the distal part of implant DBM_dist.
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Figure 3. Soft X-ray images of DBM implants DBM_dist (left) and DBM_prox (right) at four 
different times after implantation. (a, b, c) In-vivo soft X-ray images at weeks 1, 3, and 5, 
respectively. The estimated location of both implants is indicated with a white box. (d) Post-
explantation soft X-ray images at week 7. The ﬁrst ossiﬁcation-related contrast appears in 
block DBM_prox at week 5 (arrow). The post-explantation X-ray image of implant DBM_prox 
shows complete, uniform, bone formation. In implant DBM_dist bone formation is not 
found in the in-vivo soft X-ray images, not even at week 5. However, partial ossiﬁcation is 
observed in the post-explantation X-ray images at week 7.
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MRI
In the longitudinal MR imaging study (Figure 4), low-intensity (dark) 
areas became gradually apparent at week 3 (implant DBM_prox) or week 5 
(implant DBM_dist). These areas were located at the surface of the original 
DBM implants and were supposed to represent bone. At week 7 (Figure 5) 
the complete surface of block DBM_prox seemed to be uniformly calciﬁed, 
whereas block DBM_dist showed only partial calciﬁcation. This was most 
noticeable at the distal side. Similar appearing low-intensity areas could 
no be found in iDBM implants iDBM_prox (Figure 5) and iDBM_dist (not 
shown). 
Figure 4. 
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Figure 5. Bone formation at 7 weeks post implantation in three implants, DBM_prox (a), iDBM_
prox (b) and DBM_dist (c), as studied by MRI. For each implant four equidistant transverse slices 
(distance 2.0 mm) are shown from the distal side (left) to the proximal side of the implant (right). 
Low-intensity areas associated with bone formation are indicated by arrows.
Corresponding histological slices of the partially ossiﬁed implant DBM_dist are shown for 
comparison (d). Despite the difference in slice thickness and the signiﬁcant deformation of the 
implants during the post-explantation treatment for histology, MRI and histology show strong 
similarities in the geometry of bone formation of implant DBM_dist.
Figure 4. Transverse images (perpendicular to the X-ray images in Figure 3) of the distal side of the 
implants DBM_dist (left) and DBM_prox (right). (a-d) MRI at weeks 1, 3, 5, and 7, respectively, 
after implantation. (e) Histological images post-explantation at week 7. The ﬁrst signs of bone 
formation appear in the MRI at week 3 (implant DBM_prox) or week 5 (implant DBM_dist) as 
low-intensity areas located at the surface of the original implants (indicated by arrows). Both 
MRI and histology show that ossiﬁcation in the distal section of implant DBM_prox  
(right column) appears evenly distributed, whereas the distal section of implant DBM_dist  
(left column) is ossiﬁed at the left side mainly. The dark circular spot in the MRI at the right side 
of Block DBM_dist is attributed to a hemorrhage.
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Light microscopy
In DBM implants DBM_prox and DBM_dist bone formation was seen 
(Figure 4). The deposited bone had a trabecular appearance and could be 
associated with the presence of bone marrow-like tissue within the porosity 
of the bone trabeculae. The bone was also characterized by the presence of 
osteocytes that were embedded in the mineralized matrix. At the outside, 
the bone was surrounded by a periosteum-like tissue layer. In the part of 
the implant with incomplete bone formation (implant DBM_dist), the 
collagenous structure of the DBM was still visible together with ﬁbrous 
tissue ingrowth. Hardly any inﬂammatory cells were present. In iDBM 
implants iDBM_prox and iDBM_dist (not shown) no bone formation 
was seen. Only remnants of the iDBM implant were observed together 
with ﬁbrous tissue ingrowth. The enlargements in Figure 6 show an even 
distribution of bone formation throughout implant DBM_prox. Implant 
DBM_dist, however, showed only partial bone formation, most notably at 
the distal side.
Figure 6. Histology of adequate ectopic bone formation in block DBM_prox (40x) and only partial 
ectopic bone formation in block DBM_dist (10x) conﬁrms ﬁndings on MRI.
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Results of histomorphometric analysis of the sections of implants DBM_
prox and DBM_dist are shown in Figure 7. Implant DBM_prox had an 
average bone formation of 51%, implant DBM_dist of 14%. In implant 
DBM_prox distribution of bone formation was rather uniform, in implant 
DBM_dist bone formation was most pronounced at the distal part. 
Histomorphometric analysis of the sections of implants iDBM_prox and 
iDBM_dist did not reveal any signiﬁcant bone formation (less than 1%).
Discussion
Demineralized bone matrix has been shown to induce ectopic 
endochondral bone formation, when subcutaneously implanted in rats7. 
The temporal sequence of recruitment/chemotaxis and proliferation of 
undifferentiated mesenchymal cells, chondrocyte differentiation, calciﬁed 
cartilage formation, neovascularization, osteoblast differentiation, bone 
formation, osteoclastic bone remodelling, and hematopoietic marrow 
Figure 7. Histomorphometrical analysis of implants DBM_prox and DBM_dist at week 7. Implant 
DBM_prox shows an average bone surface area of 51%, which is evenly distributed over the DBM. 
Implant DBM_dist shows an average bone surface area of 14%, predominantly located at the 
distal side (slices 3-5) of the DBM.
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development is complete by 21 days. After 4M guanidine-HCl extraction 
of the native bone morphogenetic proteins (BMP’s), iDBM ceases to induce 
any bone formation. In table 1 we summarize the evidence of ectopic 
bone formation from the four different techniques on all four implants. 
Both block DBM_prox and DBM_dist proved to form ectopic bone, where 
block iDBM_prox and iDBM_dist did form almost no bone at all, quite 
as expected. Residual bone formation in block iDBM_dist (less than 1%) 
may be attributed to incomplete decalciﬁcation or incomplete extraction 
of BMPs. Decalciﬁcation and Guanidine deactivation is usually performed 
on DBM particles8-10, whereas in our study we chose to deactivate an intact 
femoral diaphysis, as shape was an important feature in our study.
In this study different methods to assess bone formation (X-ray images, 
MRI and light microscopy) are compared. Implant DBM_prox exhibited 
bone formation, which was detected by X-ray examination at week 5. 
Implant DBM_dist showed partial bone formation at the distal side of the 
implant. This could be detected by X-rays in the post-explantation phase 
only. In our experiment we could not demonstrate ectopic bone formation 
radiographically before week 5. In a study by Viljanen et al. ectopic bone 
Block A Block B Block C Block D
Soft X-ray images yes no yes1 no
MRI yes no yes2 no
Light microscopy yes no yes no
Histomorphometry yes3 no yes4 no
1) Only partial ectopic bone formation is observed  2) Ectopic bone formation is observed at the distal side only
3) 50%    4) 14%
Table 1. Evidence of ectopic bone formation from four different techniques on all four blocks of 
implanted DBM. As expected, only block DBM_prox and DBM_dist showed bone formation. 
Block DBM_prox had an even distribution of bone formation, in block DBM_dist bone was 
formed at the distal side only
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formation was found as early as in week 3, using radiomorphometric 
quantiﬁcation11. Moreover, in this study almost complete ossiﬁcation was 
reported, whereas in our experiment we ﬁnd 51% and 14% ossiﬁcation 
only. The variable osteogenic potential of DBM is well recognized12-14. In 
contrast to our study, Viljanen et al. implanted DBM in a muscle ﬂap, 
which is known to have greater potential for ectopic bone formation than 
subcutaneous tissue15. Furthermore, the age of the acceptor rats that were 
used was 5 to 6 weeks. In our experiment we used a 10 week old rat. Aged 
animals show a decreased ability to produce bone in response to DBM16. 
Because induction is related to the surface area of exposed matrix, the use 
of DBM powder instead of femoral shafts would have given more bone 
formation in our experiment17.
MRI was able to detect bone formation in an earlier phase both for implant 
DBM_prox (3 weeks) and DBM_dist (5 weeks). Besides detection of bone 
formation, MRI was able to assess the localization of bone formation at 
the distal side of the implant. Bone formation was conﬁrmed by light 
microscopy for both implant DBM_prox and DBM_dist. Histomorphometry 
conﬁrmed that the bone formation of implant DBM_dist was localized 
at the distal side only. Recently Traoré described the use of MRI for the 
monitoring of biological changes of implanted porous biomaterials18, but to 
our knowledge MRI has not been used for the monitoring of ectopic bone 
formation in the study of bone tissue engineering19.
In the present study all MRI scans were carried out at 7.0 T, whereas most 
clinical MRI scanners presently use ﬁeld strengths between 0.5 and 1.5 T. 
This relatively high magnetic ﬁeld strength was used to obtain sufﬁcient 
signal-to-noise ratio and spatial resolution necessary for the small size of 
the rat DBM implants. However, we may expect that the presented proton-
density weighted MRI method can be used at lower ﬁeld strengths for 
human studies as well3.
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Conclusion
This explorative animal study showed that MRI appears to be a valuable 
tool in bone tissue engineering studies. Using MRI bone formation can be 
detected earlier than by soft X-rays. Besides, the complete three-dimensional 
shape of the newly formed bone can be monitored noninvasively. An 
additional advantage is that in comparison with histology, this technique 
requires less animals for longitudinal studies and that interanimal variation 
can be prevented, on the other hand a comparative study will be needed 
in which all diagnostic studies are performed at each follow-up, and this 
should be performed blindly.
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Introduction
In reconstructive bone surgery donor site morbidity is a consequence of the 
use of autogenous grafts1. Tissue engineering is a promising new technique 
which can help to minimize this donor site morbidity by creating a Bone 
Graft Substitute (BGS). As part of our efforts to produce BGS’s, we explored 
in a previous study the feasibility of using Magnetic Resonance Imaging 
(MRI) as a method to assess bone formation in tissue engineered bone 
constructs2. In this pilot study, demineralized bone matrix (DBM) implants 
were inserted subcutaneously in just one single rat. Subsequently, at 1, 3, 5 
and 7 weeks post implantation, MRI was done to monitor bone formation 
in the implants. The results showed that: (1) in vivo MRI is suitable to 
check bone formation non-invasively, and (2) MRI results match well with 
histology results obtained at 7 weeks. However, in this preliminary study, 
no attempt was made to quantify the MRI results and to compare the 
quantitative MRI data with standard histomorphometry. Therefore, the ﬁrst 
aim of the current study is to continue and expand our in vivo MRI studies 
for bone engineering applications.
Besides the use of MRI to produce pictures of body tissue, MRI technology 
can also be utilized to detect blood vessels. This so-called MR Angiography 
(MRA) provides detailed information about the functionality of blood 
vessels without using any contrast material. At this point, it appears 
appropriate to emphasize that the ﬁnal goal in our bone engineering 
studies is to create a prefabricated and preshaped bone graft consisting of 
an osteoinductive scaffold combined with a vascularised muscle ﬂap, which 
can be transplanted microsurgically to the receptor area. Maintenance 
of blood ﬂow is of major importance for the ﬁnal success of such free 
ﬂap constructs. Consequently, the second aim of the present study was 
to determine whether MRA is indeed a useful method to determine the 
functionality of the supplying blood vessel in such pedicled bone graft 
substitutes.
A third aim of the current study was to evaluate also another technique for 
the assessment of bone formation, i.e. Dual Energy X-ray Absorptiometry 
(DEXA). This is a fast, cheap and reproducible method to examine bone 
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mineral content and density in clinical practice3, 4. In addition, the efﬁcacy 
of this technique for the measurement of bone formation in porous 
implants has been reported5, 6.
Considering these three aims, we created pedicled muscle ﬂaps in rats, 
which were wrapped around DBM implants. Two groups of rats were formed 
in our study: a so-called early (six weeks) and late (twelve weeks) group. In 
vivo MRI and post-mortem histology were used to evaluate bone formation 
in the early group. Also, MRA was performed to watch the functionality of 
the blood vessel in the pedicled DBM implant. For the late group, in vivo 
DEXA and post-mortem histology were used for bone formation analysis. 
Materials and methods 
Implants
The femora of seven male Wistar donor rats (10 weeks old) were used to 
prepare 14 DBM-implants. From each femur the bone marrow was removed 
and one cm sections of the diaphyses were made. These were immediately 
chilled to 0°C and then decalciﬁed in hydrochloric acid (HCl) (1 g bone per 
100 ml 0.6 N HCl) under constant stirring during 48 hours at a temperature 
of 20ºC. The HCl was refreshed after 24 hours. After dilution of the acid 
with 0.15 N NaCl, the implants were lyophilized and stored at minus 20°C. 
The average weight of the DBM implants was 19 ± 4 mg.
Implantation procedure
Fourteen male Wistar rats (W.U., 10 weeks of age, average weight 280 g) 
were used in the study. Before surgery, the animals were anaesthetized using 
a mixture of 50% oxygen with 50% nitrous oxide and 1.2% Isoﬂurane  
(1-chloro-2,2,2-triﬂuoroethyl-diﬂuoromethyl-ether). For the insertion of the 
implants, the animals were immobilized and placed in a supine position. 
During the implantation procedure the core temperature was registered 
with a rectal probe and maintained with a variable-temperature circulating-
water bed. The skin of the animals was shaved, washed and disinfected 
with povidone-iodine. After incising the skin on the medial side of the hind 
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limb, the saphenous vessels were distally ligated, just above the point where 
the vessels split in two or three branches. The anterior and posterior gracilis 
muscles were elevated from distal to proximal, preserving the branches of 
the saphenous vessels to these muscles. Proximally from the muscles, the 
saphenous vessels originate from the femoral vessels. All other branches 
from the femoral vessels were ligated and cut to provide an optimal blood 
ﬂow to the muscle ﬂap. Each animal received one DBM implant, which 
was wrapped in the adductor thigh muscle ﬂap7. The ﬂap was closed with 
non-absorbable monoﬁlament 7x0 sutures (Nylon). Around this muscle 
ﬂap, a 1.5 x 1.0 cm silicon sheet with a thickness of 0.5 mm was wrapped to 
prevent vascular ingrowth from the surrounding tissues. Consequently, the 
ﬂap was vascularised solely from its pedicle. At the end of the operation, the 
skin was closed with stainless steel staples.
 
After surgery, the animals were randomly assigned to two groups. The 
early group (n=7) was maintained for six weeks and the late group (n=7) 
was maintained for twelve weeks. At six weeks after implantation, MRI/
MRA was obtained from all rats of the early group. Thereafter, the animals 
were killed by an overdose of ether anesthesia and implants together with 
surrounding tissues were retrieved for histological evaluation. Twelve weeks 
after implantation, DEXA scans were obtained for all rats belonging to the 
late group. Subsequently, also these animals were killed and implants plus 
surrounding tissue retrieved for histological analysis.
The used animal protocol was approved by the Animal Care Ethics 
committee of the University of Nijmegen. The animal experiments were 
performed according guidelines for animal experiments for scientiﬁc 
research of the Dutch government.
Evaluation techniques
Magnetic Resonance Imaging (MRI) / Magnetic Resonance Angiography (MRA)
All MRI and MRA experiments were carried out on an S.M.I.S. 7 Tesla MRI 
scanner with a 200 mm bore size dedicated for small test animals. Animals 
were placed into the magnet, face down, on top of a 22 mm radiofrequency 
(RF) surface coil covering one DBM-implant at a time. During the MRI/MRA 
investigation, the rat was anesthetized as indicated in the implantation 
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procedures, the respiration rate was continuously monitored, and the core 
temperature was maintained as indicated in the implantation procedures. 
For the MRI experiment we used a gradient-echo sequence (TE = 6 ms; 
TR = 1000 ms; ﬂip angle = 60°; ﬁeld of view = 55 mm; matrix size = 512 x 
512 data points). The images show mainly proton-density weighting. As 
shown in a previous paper, areas with newly formed bone will appear dark 
(“calciﬁcation”) in proton-density weighted images in contrast to non 
responding DBM, which appear white (“no calciﬁcation”)2. After a trial 
scan to establish the orientation of the DBM implants, 24 parallel slices 
(thickness 0.7 mm; separation 1.0 mm) were acquired perpendicular to 
the long axis through the DBM. As the length of the DBM implants was 
10 mm, each DBM was visible in 10 contiguous slices. The percentage 
of “calciﬁcation” in each slice was calculated. Thereafter, the data for 
the separate slices were averaged, which resulted in a volume percentage 
calciﬁcation of the total implant volume, i.e. 45% calciﬁcation means 45% 
of the total implant volume. Finally, the same slices were imaged with an 
MRA sequence (TE = 6 ms; TR = 200 ms; ﬂip angle = 90°) as well. In these 
images, regions with large ﬂow (functional blood vessels) appear white, and 
other areas appear dark. Thus the MRA images can be used to demonstrate 
the integrity of the vascular pedicle. 
DEXA
DEXA scans were performed on a Hologic QDR 1000 scanner (Waltham, 
MA). The rats were anesthetized using halothane/nitrous oxide/oxygen 
inhalation anesthesia and placed prone on the scanner. The hind limbs 
were ﬁxed to prevent projection of the femur over the implant. After 
acquiring a scan of the hind limb area, the femora and the DBM implants 
were identiﬁed. It was attempted to quantify the bone mineral content of 
the DBM by positioning regions of interest over the location of the implant 
and over the surrounding tissues.
Histological analysis
The specimens were retrieved for histological analysis: they were ﬁxed and 
stored in phosphate-buffered 4% formalin solution (pH = 7.4). Then, the 
tissue blocks were dehydrated in a graded series of ethanol and embedded 
in methyl-methacrylate (MMA). Subsequently, 10 µm sections of the 
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MMA embedded samples were made using a modiﬁed sawing microtome 
technique8. At least three transversal sections were made on ﬁve different 
levels in each implant. These levels corresponded with the transverse 
slices of the MRI evaluation. The sections were stained with methylene 
blue and basic fuchsin. To evaluate the tissue response to the implants, 
both histological and histomorphometrical analysis was performed. The 
histological evaluation consisted of a complete description of the observed 
thin sections.
A computer based image analysis system (Qwin Pro, version 2.3, Leica, 
Wetzlar, Germany) was used for histomorphometrical analysis. Two 
parameters were assessed: (1) the surface area of the newly formed bone, 
and (2) the surface area of the DBM implant. In this way the relative bone 
formation could be measured. All histomorphometrical measurements were 
performed in the ﬁve different transverse sections of each implant, which 
were averaged to obtain the ﬁnal result.
Statistical procedure
Results were expressed as mean + one standard deviation (SD). To test 
the correlation between MRI and histomorphometry a linear correlation 
analysis was done. Data of the histomorphometrical analysis were compared 
with an unpaired t test. The test was performed at 95% conﬁdence level. 
The t test assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption was tested using the method of 
Kolmogorov and Smirnov. All calculations were performed in GraphPad 
Instat version 3.05 for Windows 95/NT (Graphpad Software, San Diego, 
California, USA).
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Results
Clinical observations
One of the rats of the early group died after surgery. Therefore, this group 
ﬁnally consisted of 6 rats. All rats showed an undisturbed wound healing 
without any clinical signs of inﬂammation at the surgical sites during the 
various implantation times.
Early group
MRI/MRA
Six implants were evaluated by MRI and MRA. The quantitative data for 
these six implants are presented in Fig. 1. In four implants clear bone 
formation was observed on MRI, all of them having an intact vascular 
pedicle on MRA (Fig. 2). Two implants showed only minimal bone 
formation, while the patency of the pedicle could not be proven by MRA. 
The mean relative bone formation for all implants was 42% ± 35%.
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Figure 1. Quantitative MRI data for implants in the early group: four implants (1, 2, 5 and 6) show 
marked bone formation, two implants show almost no bone formation.
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MRA
Figure 2. MRI and MRA of DBM implant. Upper ﬁgure (MRI): bone formation is visible as a dark 
ring. A silicon sheet is clearly visible (caret). Explanation of the tissue structures as visible in the 
MRI image. Lower ﬁgure (MRA): the white spot represents ﬂow in the vascular pedicle of the ﬂap.
MRI
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Descriptive light microscopy
Light microscopy conﬁrmed the MRI results, i.e. bone formation was seen 
in only four of the six specimens. Bone formation was characterized by the 
occurrence of mineral deposits inside the DBM material. Bone was deposited 
in islands and was not present as a continuous phase in the DBM. Bone 
formation could be associated with the presence of osteoblasts, osteoid and 
osteocytes (Fig. 3). Inside the bony islands, cavities were present that were 
ﬁlled with bone marrow-like tissue. Bone formation did not expand outside 
the original geometry of the DBM specimens. At the outer surface, the 
specimens were surrounded by a ﬁbrous tissue capsule. No inﬂammatory 
response inside the capsule or at the capsule-DBM interface was observed.
Figure 3. Histology of an early group specimen: ectopic bone formation at 6 weeks (original 
magniﬁcation: 1.6x; enlargement 20x).
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Histomorphometry
Unfortunately, one specimen could not be used for histomorphometrical 
evaluation, since the available sections were of insufﬁcient quality to allow 
a reliable quantiﬁcation of the relative bone formation. The results of the 
other ﬁve measurements are depicted in Fig. 4. Three implants showed 
bone formation of 25% or more of their total surface area. The other two 
implants had bone formation of less than 10%. The mean relative value of 
bone formation for all implants was 25 ± 19%.
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Figure 4. Histomorphometrical analysis of bone formation in early group: three implants
(1, 2 and 5) show marked bone formation, two implants show almost no bone formation.
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Comparison of MRI and histomorphometry data
To determine the existence of a relationship between MRI and histomorpho-
metrical evaluation, a linear correlation analysis was done. The calculated 
correlation coefﬁcient r was 0.9395 and the coefﬁcient of determination (r2) 
was 0.8827. This indicates the existence of a strong correlation.
Late group
DEXA
The autologous rat femurs were well-visualized. However, the density of 
the implants was hardly discernable from the soft tissues. At best, the 
implants were only faintly visualized, indicating a very low bone mineral 
content. Consequently, region-of-interest quantiﬁcation did not yield any 
reproducible results, since it was impossible to reliably discriminate the 
implant from the surrounding soft tissues.
Descriptive light microscopy
Histological analysis seemed contradictory to the DEXA observations. In 
ﬁve of the DBM specimens, extensive bone formation was observed. Bone 
formation was again characterized by the presence of osteoblasts, osteoid 
and osteocytes in a mineralized matrix. Also, inside the deposited bone, 
bone marrow-like tissue was observed. Occasionally, bone formation 
extended throughout the DBM and ﬁlled at some sites the DBM almost 
completely. The newly deposited bone never expanded in the original 
medullar cavity of the DBM or outside the DBM material. In the other two 
specimens, also bone formation could be observed. However, the amount 
of bone was clearly less. All DBM specimens maintained their original 
shape. No sign of DBM degradation was seen. All specimens were further 
surrounded by a ﬁbrous capsule without the presence of inﬂammatory cells. 
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Histomorphometry
The bone formation data of the seven DBM implants of the late group are 
depicted in Fig. 5. Five implants showed bone formation of 45% or more of 
their total surface area. The other two implants revealed a much lower bone 
formation percentage (less than 25%). The mean percentage bone formation 
for all implants was 48 ± 15%.
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Figure 5. Histomorphometrical analysis of bone formation in late group: ﬁve implants 
(1, 2, 3, 4 and 5) show marked bone formation, two implants show no marked bone 
formation (less than 20%). 
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Comparison of early and late group data
Comparison of the histomorphometrical data for bone formation between 
the early and late groups reveals that signiﬁcantly more bone is formed in 
the late DBM group (P = 0.0463). Additional statistical testing conﬁrmed 
that the two SD’s of the early and late group did not differ signiﬁcantly 
from each other (P = 0.3011). Also, the data were shown to be sampled from 
Gaussian distributions (P > 0.10).
Discussion
The current study was an expanded follow-up analysis of an earlier 
performed pilot experiment and aimed at the use of MRI and DEXA to 
follow the progress of the bone development process in pedicled bone graft 
substitutes2. Additionally, MRA was used to study the blood circulation in 
the created muscle ﬂaps. Bone formation was evaluated in DBM implants, 
wrapped in pedicled muscle ﬂaps and inserted in rats. MRI and DEXA 
results were always compared with histomorphometrical measurement. 
Unfortunately, MRI/MRA and DEXA could not be performed on the 
same animals due to organizational and regulatory affairs. The used MRI 
equipment was available at the animal facility. DEXA equipment was 
available in the hospital and is used for patient diagnosis. As a consequence, 
DEXA measurements had to be done outside regular working hours. In 
addition, MRI for experimental animals is still a costly and time elaborative 
technique. Therefore, we decided to create two separate groups and to 
correlate the obtained data to histomorphometrical measurements. 
Considering the use of MRI for the analysis of bone development, the 
major advantage of MRI, compared to the golden standard histology, is the 
ability to perform in vivo longitudinal studies. The interanimal variation, 
which cannot be avoided in histological studies, can be prevented in this 
way. On the other hand, disadvantages of MRI are the availability of the 
equipment, costs as well as the necessity of anesthesia with the inherent 
risk of animal death. Comparison of the available MRI with histological 
data reveals the existence of a strong relationship between both methods. 
This conﬁrms that MRI is of sufﬁcient accuracy for comparative and 
sequential bone formation studies. Consequently, MRI can be a competitive 
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technique for the long term follow-up evaluation of bone graft substitutes, 
especially when larger and less elaborative equipment becomes available 
in the future. Despite this favorable outcome, we have to notice that MRI 
and histomorphometry do not provide exactly the same amounts of bone 
formation. An explanation can be found in the number of slices and the 
used bone quantiﬁcation technique. For MRI, 10 slices were evaluated 
representing the total implant. However, the imaging of these relatively 
thick slices is still a 2-D representation of a 3-D subject, which can result in 
over- or underestimation on the amount of bone formation. On the other 
hand, for the histomorphometrical analysis only a very limited number of 
sections out of a complete specimen can be analyzed, which can also result 
in over- or underestimation.
Besides MRI, longitudinal studies can also be performed using DEXA scans. 
Similar to MRI, the animals have to be anesthetized for each investigation. 
However, the investigation itself is generally very fast, cheap and widely 
available. We chose to use DEXA for the late group and to compare it with 
the golden standard of histology and histomorphometry. However, the 
bone mineral content was so low in comparison to surrounding soft tissue 
density that the graft could hardly be identiﬁed. Consequently, DEXA is 
unsuitable to reliably assess small variations in mineralization, which makes 
this technique not suitable for evaluation of bone tissue regeneration in the 
current experimental design in small laboratory animals. However, given 
the procedure’s highly reproducible evaluation of bone density and bone 
mineral content in a clinical setting, DEXA may be more suitable when 
larger animal models and larger bone constructs are used.
Bone inductive activity of demineralized bone preparations is determined 
by the amount and activity of BMPs present in the material. Increased 
bone formation is observed at higher concentrations of BMP9-12. These 
growth factors are present in cortical bone, but only in minute amounts, 
approximately 1-2 µg BMP/kg of cortical bone13. The amount of BMPs may 
vary widely depending on source14, preparative technique15 and sterilization 
method used16. The quantity of bone formation is also related to the 
surface area of exposed matrix17, 18.  Therefore, in most studies DBM is used 
as particulate and not as a massive implant19, 20. Such DBM particles were 
reported to generate 58% (± 25%) of bone in a rat craniotomy defect after 
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three weeks of implantation10. In the present study, we used DBM as bulk 
one centimeter sections of a femur. Such DBM implants have a smaller 
surface area than powder DBM. Nevertheless, bone formation after six and 
twelve weeks proved to be respectively, 25% (±19%) and 48% (± 15%). 
Concerning the maintenance of the deposited bone during time, we found 
that bone formation did not stop at six weeks, but instead continued so that 
after twelve weeks the amount of developed bone is signiﬁcantly higher 
than at six weeks. No signs of osteolysis could be detected. This corroborates 
with the ﬁndings of Viljanen et al, who also described a time-related 
increase in new bone in a rat latissimus dorsi ﬂap model with DBM, using 
radiomorphometry to quantify bone formation21. They reported a relative 
increase of the radiographic reference from 55% to 80% of rat normal bone 
average intensity at 10, 21 and 35 days. 
Additionally, we observed that two of the six week samples showed almost 
no bone formation (less than 10%). MRA suggests that this is evidently 
due to a lack of blood supply. This can be due to either kinking of the 
vascular pedicle with subsequent lack of circulation preventing formation 
of bone, or compression of the ﬂap by the silicone envelope. Post operative 
edema of the muscle ﬂap can result in a relative tightness of this silicone 
envelop with ﬂap failure as a result. Viljanen et al. already warned for this 
complication, although in their series of twelve DBM implants in a rat 
latissimus dorsi muscle ﬂap model, almost complete ossiﬁcation was found 
in all implants21.
Although, MRA was found to be a suitable technique to evaluate the 
maintenance of circulation in the supplying blood vessel in pedicled BGS’s, 
we cannot exclude that the lack of bone formation could also have been 
caused by the known and marked variation in the bone inducing capacity 
of DBM21-25. Evidently, the processing technique is important for the 
effectiveness of DBM and should therefore be standardized26. Despite of our 
efforts to be as accurate as possible, still some variation in the processing 
of the samples can have occurred. In this respect, we have to emphasize 
that DBM material has to be bioassayed prior to use in order to prevent the 
variation in osteoinductive effect27. 
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Conclusion
On basis of our observations, we conclude that in vivo MRI proved to be 
a reliable method for monitoring ectopic bone formation in a rat model, 
while in vivo DEXA was unable to detect the implants. However, since MRI 
is time consuming and expensive, it is currently still not suited to replace 
histology and histomorphometry. Furthermore, MRA proved to be a very 
useful technique for studying the circulation of muscle ﬂaps in this animal 
model.
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Introduction
In reconstructive bone surgery donor site morbidity is a consequence of 
the use of autologous tissue1. Tissue engineering is a promising tool, which 
could help to minimise this donor site morbidity. One of the materials 
that has been studied extensively in bone regeneration procedures is 
demineralized bone matrix (DBM). As an osteoinductive agent, DBM 
induces osteogenesis via endochondral ossiﬁcation2-4. The pioneering 
studies on bone induction were performed by Urist5, 6. He reported the 
isolation of a bone morphogenic protein (BMP) derived from bovine bone 
matrix gelatin by dissociative extraction in guanidine-HCl. This puriﬁed 
BMP, similar to DBM, was found to induce differentiation of mesenchymal 
cells into cartilage and bone when implanted into thigh-muscle pouches 
in mice. BMP has subsequently been isolated from rat, rabbit, guinea pig, 
porcine and human bone4. 
Glowacki and co-authors7, 8 have recommended the following choices of 
DBM implant forms:
• powdered (75-250µm) for small irregular defects
• small chips (5mm) for septic lesions
• corticocancellous blocks or strips for segmental defects
They caution that very large pieces of DBM should be avoided, since smaller 
ones have increased surface area, which ensures a greater accessibility to 
BMP9. This encourages the proliferation and differentiation of osteogenic 
cells and makes DBM granulate more osteoinductive7, 8. 
In earlier studies we have used blocks of DBM obtained from the femora 
of donor rats. These blocks were inserted subcutaneously2 as well as 
intramuscularly3 in rats. Although signiﬁcant bone formation occurred in 
both acceptor sites, we found a strong variation in bone forming capacity. 
This in contrast to Viljanen et al., who found almost complete ossiﬁcation 
in their series of 12 DBM implants in a rat latissimus dorsi muscle ﬂap 
model10. This difference in results can be due to the variation in bone 
forming capacity of the DBM itself, which has been described before11. It is 
possible that this effect was even more enhanced in our study, because we 
inserted the DBM as a block and not as a granulate.
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On basis of the above mentioned, we decided to further explore the 
osteoinductive properties of DBM implants. We hypothesized that 
morsellized DBM (MDBM) has greater osteoinductive properties than non-
morsellized DBM. Therefore, morsellized and non-morsellized DBM was 
inserted in a rat muscle ﬂap. Bone formation was investigated by histology 
and histomorphometry.
Materials and methods 
Implants
Demineralized bone matrix (DBM)
Ten 10-week male Wistar (W.U.) donor rats were sacriﬁced by an overdose 
CO2. The femora of these donor rats were used to prepare 20 DBM-implants. 
Donor femora were cleaned of adherent periosteum, muscle and connective 
tissue. From the diaphysis of the resected femora, pieces with a length of 
1.0 cm were cut and placed on ice, after ﬂushing with saline to remove the 
bone marrow. The fragments were decalciﬁed in 0.6 N HCl (1g bone per 
100 ml 0.6 N HCl) under constant stirring during 72 hours at a temperature 
of 4°C. After elution of the acid in 0.15 N NaCl, the fragments were 
lyophilized and stored at -20˚C. The average weight of the DBM was 3.1  
(± 0.4) mg.
Morsellized Demineralized bone matrix (MDBM)
Ten pieces of the previously demineralized bone matrix were morsellized by 
mortar and pestle and bone chips were remodelled in a cylindrical mould 
by impaction. The average weight of the morsellized DBM implants was 2.8 
(± 0.5) mg.
Experimental design and surgical procedure
Surgery
For implantation ten 10-week old male Wistar acceptor rats (W.U., with 
an average weight of 280 grams) were used. Surgery was performed under 
general inhalation anesthesia using a mixture of ﬁfty percent oxygen with 
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ﬁfty percent nitric oxide and 1.2% Isoﬂurane [Forene® (1-chloro-2, 2,2-
triﬂuorethyl-diﬂuoromethyl-ether)]. For the insertion of the implants, the 
animals were immobilized and placed in a supine position. Longitudinal 
skin incisions were made on the medial surface of both hind legs of the rat, 
from the ankle to the groin above the inguinal ligament. After the incision 
was made, an intramuscular pocket in the adductor thigh muscle was 
created by blunt dissection. The DBM implants were placed in the pocket, 
and the muscle and skin were closed using Agraven suture material. Each 
animal received one DBM implant as well as one morsellized DBM implant 
on the contralateral side. To assure statistical randomization, DBM implants 
were alternately placed on the right or left side. In total 20 implants were 
placed. Six weeks after surgery the animals were sacriﬁced using an overdose 
of CO2 anesthesia. 
The used animal protocol was approved by the Animal Care Ethics 
committee of the University of Nijmegen. The animal experiments were 
performed according guidelines for animal experiments for scientiﬁc 
research of the Dutch government. 
Light microscopic evaluation
After sacriﬁcing the animals, the implants with their surrounding tissue 
were retrieved and prepared for histological and histomorphometrical 
evaluation. For one implant histological and histomorphometrical 
evaluation was not possible as it was completely resorbed during the 6 
weeks of implantation in the intramuscular pocket. All other implants were 
ﬁxed in 4% buffered formaldehyde solution. Subsequently, the tissue blocks 
were dehydrated in ethanol and embedded in methylmethacrylate. 
After polymerization, thin sections (thickness 10 µm) were made using 
a modiﬁed sawing microtome technique12. Transversal sections were 
made on 3 levels in each implant, with 3 slices per level. To be able to 
differentiate cartilage, bone, marrow and muscle the sections were stained 
with methylene blue (15 sec.) and basic fuchsin (30 sec.) and examined 
with a light microscope. To evaluate the tissue response to the implants, 
both histological and histomorphometrical evaluation was performed. The 
histological evaluation consisted of a complete description of the observed 
thin sections. For the histomorphometrical measurements image analysis 
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techniques were performed. Therefore a computer based image analysis 
system (Leica Qwin) was used. The following parameters were assessed:
• DBM respectively MDBM surface area
• Surface area bone formation
• All histomorphometrical measurements were performed in 9 different      
   sections per implant. Presented results are based on the average of these 
   measurements.
Results
Histological analysis
In DBM implants and morsellized DBM implants bone formation was seen 
(Figure 1). However, a wide variation in the occurrence as well as amount 
of new bone formation was observed. In four out of nine DBM and one 
out of nine MDBM implants even no bone formation at all occurred. 
The deposited bone in the DBM implant had a trabecular appearance 
and could be associated with the presence of bone marrow-like tissue 
within the porosity of the bone trabeculae. The newly formed bone in 
the MDBM implants showed a more compact appearance than seen in 
the DBM implants. The bone was always characterized by the presence of 
osteocytes that were embedded in the mineralized matrix. At the outside, a 
periosteum-like tissue layer surrounded the bone. As shown in Figure 1 the 
shape and size of the MDBM implants are different from the DBM implants. 
Figure 1a and b. Bone formation at 6 weeks implantation in two implants, DBM (a) and MDBM (b) as 
studied by histology shows bone formation in both groups. 
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The natural oval-shape and collagenous structure of the DBM is hardly 
recognizable, as the MDBM implants have a more elongated form. Also, 
the location of the bone formation differed, i.e. in non-morsellized DBM 
distribution of bone formation was most pronounced at the distal part, 
while in morsellized DBM bone formation was most pronounced centrally. 
Almost no inﬂammatory cells were present close to the DBM or in between 
the MDBM particles, except for one DBM implant, where an inﬂammation 
was seen, which was associated with a lack of new bone formation. 
Histomorphometrical evaluation
Results of histomorphometric analysis of the sections of both implants 
are shown in Figure 2. In average 2.6% of bone formation was measured 
in DBM implants with a range from 0% to 14%. In MDBM implants, in 
average 1.9% bone formation was measured with a range from 0% to 9%. 
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Figure 2. Histomorphometrical analysis of non-morsellized DBM and morsellized DBM showed 
limited bone formation for both groups. Non-morsellized DBM had an average bone formation of 
2.6 %, morsellized DBM 1.9%. There was no signiﬁcant difference between these two groups.
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Discussion
Demineralized bone matrix has been shown to induce ectopic 
endochondral bone formation, when intramuscularly implanted in rats. 
This study was designed to investigate whether increasing the surface 
area of DBM by morsellizing makes it more osteoinductive. This was done 
by comparing the osteoinductive properties of morsellized versus non-
morsellized DBM by histology and histomorphometry. As described in 
previous reports, the induction of bone is related to the surface area of the 
exposed matrix. By morsellizing the DBM implant, the surface area increases 
and the structure of the implant becomes less compact and therefore more 
osteoinductive7, 8. Nevertheless, in this study we did not observe a difference 
between the amount of bone formation of DBM versus MDBM. Besides, we 
found that the new bone formation was very limited and showed a wide 
variance for both material preparations. 
Earlier performed studies5, 8, 11, 13. showed general guidelines and test 
methods for assessment of the effectiveness of materials intended to induce 
bone formation when implanted in vivo. Following these guidelines we 
used in our experiment 10 week old rats of the male gender. Though 
gender is not a factor, the animals should be adolescent or young adults as 
older animals do not respond as effectively to osteoinductive materials14. 
Furthermore, we placed the implants in an intramuscular pocket in the 
adductor thigh muscle, as this site has proven to have greater potential for 
ectopic bone formation than subcutaneous tissue15. Also, we included on 
basis of previous studies, a sufﬁcient number of samples per group in order 
to conﬁrm the activity of DBM and to detect differences. Considering the 
fact that we met all these study design criteria, the following explanations 
can be given and remarks can be made dealing with our observations. 
Firstly, the limited amount of new bone formation conﬁrms again that 
demineralized bone is variable in its osteoinductive potential10, 11, 16.  
Of course, failure to detect reproducible bone induction using 
demineralized freeze-dried rat bone powder may be due to processing 
problems. For example, we know that the complete removal of all 
potentially inﬂammatory or antigenic substances is very important, since 
this can inhibit the osteoinductive properties of the DBM. Therefore, we 
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followed a detailed procedure for the preparation of demineralized bone 
powder, which had been proven successful before8. In view of this, we have 
to notice that the inherent variability between donors and also unknown 
surgical as well as donor conditions can interfere with bone inductivity. In 
order to learn more about the importance and relevance of such difﬁcult 
to control variables, it appears to be a prerequisite that in future studies 
controls with proven osteoinductive characteristics are included in the 
study design. 
Secondly, comparison with our earlier subcutaneous DBM suggests that 
implant location is not a very relevant parameter for bone inductivity. This 
corroborates with one of our other studies in which we inserted titanium 
ﬁber mesh implants provided with bone marrow cells in the thigh muscle 
and subcutaneous tissue of rats17. Bone formation, as induced by the 
marrow cells, was observed in all titanium meshes, but the location of the 
construct did not have an effect at all on the initiation as well as amount of 
bone formation.
Finally, we have to notice that we cannot exclude that more bone formation 
occurred in our specimens than determined in the histomorphometrical 
analysis. Histology is a destructive and time consuming technique. For 
example, only nine sections (at three different locations) could be analyzed 
in the current study. Bone formation in between the sections and selected 
areas will be missed and is impossible to avoid. Therefore, besides histology, 
other non-destructive methods, like micro-computer tomography (micro-
CT), have to be recommended for the evaluation of bone formation in 
osteoinductivity studies.
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Conclusion
Although in the literature it has been stated that the surface area of DBM 
is an important factor in the bone forming capacity of DBM, our results do 
not support this theory: enlargement of the surface area by morsellizing 
DBM implants did not lead to more bone formation. Signiﬁcant amounts 
of newly formed bone were present in some DBM as well as MDBM 
implants while in others no or very little new bone was found. Still, the 
amount of bone formation was limited compared with previous studies. 
Therefore, in order to learn more and exclude unknown experimental 
variables, the inclusion of positive bone inductive controls as well the use 
of non-destructive analysis methods has to be recommended for future 
osteoinductivity studies.
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Introduction 
Bone Graft Substitutes (BGS’s) can be fabricated by the interaction of three 
key components: 1) competent bone-forming cells, 2) a suitable framework 
or scaffold, and 3) the presence of biological stimulants1. Based on these 
three components, a classiﬁcation system for BGS has been developed by 
Laurencin and Khan2. According their description, cell-based, factor-based, 
ceramic-based, polymer-based and metal-based BGS can be discerned. 
Worldwide a lot of work has already been done to develop the ideal BGS 
that can be applied in patients for the repair and regeneration of large 
skeletal defects2, 3. Although some promising results have been reported, 
till now the outcome with such so-called tissue engineered bone grafts 
are not so consistent as hoped for. This is especially true for the cell-based 
approaches4-6. Consequently, the ideal BGS is not available yet. In view of 
this, the overall aim of the research as performed in our laboratory is to 
obtain more knowledge and understanding of the osteoinductive capacity 
of cell-based bone graft systems and how such constructs can be used to 
direct the bone healing process.
Considering the inconsistent results with cell-based BGS, we know that 
the cellularity and vascularity of the recipient bed are very important 
parameters in the bone formation process7, 8. The importance of vascularity 
has also been conﬁrmed in animal studies where factor-based BGS were 
used. For example, Khouri found skeletal muscle the optimal responding 
tissue for BMP-3 induced bone formation in the rat and hypothesized 
that muscle tissue with its blood vessels and their associated pericytes is 
a rich source of stem cells capable of responding to bone morphogenetic 
proteins9. Yoshida used recombinant human bone morphogenetic protein-
2 and atelopeptide type-I collagen as a carrier in intramuscular and 
subcutaneous sites in the rat and found also a signiﬁcant difference in 
favor of the intramuscular implants at 7 and 21 days10. Okubo observed 
a similar preference for intramuscular bone formation and claimed that 
the variations of osteoinductive activity of rhBMP-2 in various sites 
might be due to differences in the blood supply11. This importance of 
the blood supply was also conﬁrmed by Kusumoto, who used rhBMP-
2 and atelopeptide type-I collagen in a rat latissimus dorsi ﬂap8, 12. The 
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osteoinductive activity of rhBMP-2 in tissue with low blood ﬂow has been 
proven to be less than in normal tissue13. Besides the presence of pericytes 
as a source for stem cells, vascularity has also an effect on oxygen and 
nutrient supply, Hereby, a low oxygen concentration favors chondrogenesis, 
while a higher oxygen supply supports bone formation14.
To this end, it can be hypothesized that vascularity of the recipient site is 
also important for the osteoinductive capacity of a cell-based BGS. When 
this is true, then a muscle recipient site has to be preferred above  
a subcutaneous recipient site due to the higher vascularity of muscle  
tissue15, 16. To prove this hypothesis, titanium (Ti) ﬁber mesh implants 
were seeded with rat bone marrow cells (RBM) and implanted either 
subcutaneously of intramuscularly in the adductor thigh muscle of the rat. 
The amount of bone formation after one, three and six weeks was evaluated 
by histology and histomorphometry as well as by determining the calcium 
content inside the constructs.
Materials and methods 
Implants: 
Forty-eight sintered porous Ti-ﬁber mesh implants with a volumetric 
porosity of 86%, density of 600 g/m2 and a ﬁber diameter of 50 mm 
were used as scaffold material. The titanium ﬁber mesh is fabricated by 
interengaging and intertwining a multiplicity of thin titanium ﬁbers. The 
ﬁbers are bond at their points of contact using a sinter process. This results 
in a very open interconnected porosity. The average pore size of the mesh 
was about 250 µm. The diameter of the implants was 6 mm, the thickness 
0.8 mm and the weight about 15 mg. All specimens were sterilized by 
autoclavation at 121ºC for 15 min.
Cell culture technique:
The rat bone marrow cell culture technique was used as described by 
Maniatopoulos17. RBM cells were obtained from femora of 16 syngeneic 
male Fisher 344 rats (150-170 g, 6 weeks old). Femora were washed twice 
in αMEM (Minimal Essential Medium; MEM Gibco BRL, Life Technologies 
B.V.) with 0.5 mg/ml gentamycin and 3 µg/ml fungizone. Epiphyses were 
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cut off, and both diaphyses were ﬂushed out, using a-MEM supplemented 
with 10% fetal calf serum (FCS; Gibco), 50 mg/ml freshly prepared ascorbic 
acid, 10 mM Na-β-glycerophosphate, 10-8M dexamethasone and 50 µg/ml 
gentamycin (Sigma Chemicals, St. Louis, MO). Per two femora 15 ml of this 
medium was used to generate a cell suspension. This cell suspension was 
distributed over three tissue culture ﬂasks per two femurs. Finally, cultures 
were incubated in a humidiﬁed atmosphere of 95% air and 5% CO2 at 37ºC. 
After six days of primary culture (day 0), cells were detached using trypsin/
EDTA (0.25% w/v trypsin/0.02% EDTA) (Sigma) and concentrated by 
centrifugation at 1500 rpm for ﬁve minutes and resuspended in medium. A 
Coulter counter was used to count the cells. The cell suspension was diluted 
to 5 * 106 cells/ml in complete media. Subsequently, cells were seeded into 
the carrier materials. The specimens were loaded by placing the carrier 
materials in a cell suspension of 5 * 106 cells/ml (four ml cell suspension per 
24 Ti-mesh discs). After a brief exposure to a vacuum with a 50 ml syringe, 
the tubes with the cell suspension and meshes were placed in an incubator 
(95% air, 5% CO2, at 37ºC). Every 30 minutes the tubes were shaken 
manually. After four hours the meshes were removed from the suspension 
and placed in 24 well-plates. Subsequently, one ml of medium was added to 
each well. All constructs were cultured for one day prior to implantation18. 
Subsequently, all constructs were transported to the animal facility.
Implantation procedure
For implantation 24 four-week-old syngeneic Fisher 344 male rats were used. 
Surgery was performed under general inhalation anesthesia with nitrous 
oxide and oxygen. The RBM loaded meshes were subcutaneously implanted 
into the back of the animals and intramuscularly in the adductor thigh 
muscle of the leg. For the insertion of the subcutaneous implants, the animals 
were immobilized and placed in a ventral position. The back of the animals 
was shaved, washed and disinfected with povidone-iodine. A longitudinal 
incision was made on one side of the vertebral column. Lateral of the incision 
a sub-cutaneous pocket was created using blunt dissection. After placement of 
the implants the skin was closed, using Agraven suture material. 
For the insertion of the intramuscular implants in the adductor thigh 
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muscle, the animal was placed in a supine position. The groin and leg area 
were shaved, washed and disinfected with povidone-iodine. A longitudinal 
incision was made in the groin and leg, the incision was through the fascia 
and a pocket was made into the adductor thigh muscle. The implants were 
placed into this pocket. Each animal received one subcutaneous implant 
and one intramuscular implant. A total of 48 implants were placed: 
24 subcutaneous Ti implants suspension-loaded with RBM cells (Ti/R-BM/s) 
and 24 intramuscular Ti implants suspension-loaded with RBM cells (Ti/R-
BM/im). 
All subcutaneous implants were placed on the left or right side of the 
animal, alternately and the intramuscular implants were subsequently 
placed in the contralateral leg.
Implantation periods were one, three and six weeks. At the end of each 
implantation period eight rats were sacriﬁced (n=8 for each material, 
acceptor site and time period).
Further, four rats out of the six week group received sequential triple 
ﬂuorochrome labeling. Fluorochrome labels (i.e. tetracycline, alizarin-
complexon and calcein (25 mg/kg body weight) were administered at one, 
three and ﬁve weeks respectively.
The animal experiments were performed according guidelines for animal 
experiments for scientiﬁc research of the Dutch government. The used 
animal protocol was approved by the Animal Care Ethics committee of the 
University of Nijmegen.
Evaluation techniques
Histology
Four specimens of every type and time period were retrieved for histological 
analysis: they were ﬁxed and stored in phosphate-buffered 4% formalin 
solution (pH = 7.4). Then, the tissue blocks were dehydrated in a 
graded series of ethanol and embedded in methyl-methacrylate (MMA). 
Subsequently, 10 µm sections of the MMA embedded samples were made 
using a modiﬁed sawing microtome technique19. At least three transverse 
sections were made of each implant. The sections were stained with 
methylene blue and basic fuchsin. Additionally, in the six week group, two 
slightly thicker sections (30 mm) were made per implant for analysis with 
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a ﬂuorescence microscope. To evaluate the tissue response to the implants, 
both histological and histomorphometrical analysis was performed. The 
histological evaluation consisted of a complete description of the observed 
thin sections.
A computer based image analysis system (Qwin Pro, version 2.3, Leica, 
Wetzlar, Germany) was used for histomorphometrical analysis. Two 
parameters were assessed: (1) the surface area of the newly formed bone and 
(2) the surface area of the titanium implant. In this way the relative bone 
formation could be measured. All histomorphometrical measurements were 
performed in the three different transverse sections of each implant, which 
were averaged to obtain the ﬁnal result.
Calcium content
The other four implants of every type and time period were used for 
assessment of calcium content. These implants were lyophilized and 
subsequently weighed. After that, the implants were cut in half and then 
weighed again. All measurements were corrected for weight. The specimens 
were kept at -80ºC.
After thawing, one ml of acetic acid was added to every sample and stored 
overnight under constant shaking. The calcium content was determined 
using the orthocresolphthalein OCPC method with an Elisa reader at 575 
nm20.
Statistical analysis
Obtained data were compared among and within the groups using an 
ANOVA with a Tukey multiple comparison post-test. Differences were 
considered to be signiﬁcant at P values less than 0.05. Before testing, all data 
were log transformed because Bartlett’s test suggested that the differences 
among the standard deviations of the various experimental groups were 
signiﬁcant. All statistical analyses were performed with GraphPad® Instat 
3.05 software (GraphPad Software Inc., San Diego, Ca, USA). 
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Results
Clinical observations
All rats showed an undisturbed wound healing without any clinical signs of 
inﬂammation at the surgical sites during the various implantation times. At 
retrieval, both subcutaneous and intramuscular implants were surrounded 
by a thin reaction-free ﬁbrous capsule.
Descriptive light microscopy
One week implants
One week after implantation, all intramuscular and subcutaneous 
implants were surrounded by a thin ﬁbrous capsule, which was ﬁve to 
eight cell layers thick. No inﬂammatory reaction was found outside the 
capsule. Already ﬁbrous tissue had penetrated in between the Ti ﬁbers. 
This ﬁbrous tissue still lacked a clear organization and contained only a 
very low number of inﬂammatory cells. In both the subcutaneous and 
intramuscular implants, there was an abundant ingrowth of capillaries. In 
three subcutaneous and three intramuscular implants, bone formation was 
observed inside the mesh porosity. This bone had a granular appearance 
and was deposited in small islands. Occasionally, cells were observed to 
be included in the deposited bone matrix. The bone islands were always 
surrounded by hypertrophic cartilage-like cells (Fig. 1).
Figure 1. One week post-implantation, deposited 
bone mineral in an intramuscular implant is 
surrounded with hypertrophic cells. Original 
magniﬁcation 40x.
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Three week implants
All three week implants were still surrounded by a thin ﬁbrous capsule 
without the presence of inﬂammatory cells. Inside the mesh porosity 
of the subcutaneous and intramuscular implants, the ﬁbrous tissue had 
become more organized, as characterized by the occurrence of collagen 
bundles. Almost no inﬂammatory cells were seen in the mesh porosity. 
Bone formation in the mesh porosity was observed in two subcutaneous 
and three intramuscular implants. The amount of deposited bone was 
deﬁnitely increased compared with the one week implants. Osteocytes 
could clearly be recognized within the mineralized bone matrix (Fig. 2). At 
the periphery of the deposited bone, osteoid and osteoblasts could be seen. 
Bone formation appeared to grow from the centre to the periphery of the 
implant (Fig. 3).
Figure 2. Three weeks post-implantation, osteocytes 
can be recognized in the mineralized bone matrix. 
Original magniﬁcation 20x.
Figure 3. Three weeks post-implantation: bone 
appears to grow from the center to the periphery 
of the subcutaneous implant. No bone formation 
outside the area of the implant is observed. Bone 
formation appears to grow from the centre to the 
periphery of the implant. Original magniﬁcation 
1.6x.
Figure 4. Six weeks post-implantation: cavities ﬁlled 
with bone marrow-like tissue were seen within 
the deposited bone. Original magniﬁcation 20x.
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Six week implants
In the six week group, the appearance of the ﬁbrous capsule around the 
intramuscular as well subcutaneous implants had not changed compared 
with the three week implants. The same was true for the ﬁbrous tissue 
inside the mesh porosity. Bone formation was now observed in three of the 
subcutaneous and two of the intramuscular implants. The deposited bone 
had further matured compared with the three week specimens. In addition, 
cavities ﬁlled with bone marrow-like tissue were seen within the deposited 
bone (Fig. 4). The appearance of the bone in the subcutaneous as well as 
intramuscular implants was the same. Subjectively, the amount of bone 
appeared to be not further increased in the subcutaneous or intramuscular 
implants compared with the three week specimens.
Fluorescence microscopy
Fluorescence microscopy conﬁrmed the formation of mineralized tissue 
after six weeks. The ﬂuorescent labels that stained the mineralization front, 
demonstrated that bone formation started from the center of the implant 
and proceeded to the periphery (Fig. 5). The mineralization speed could be 
measured for week three till week ﬁve by measuring the distance between 
the two differently stained mineralization lines: this amounted to seven µm 
in two weeks.
Figure 5. Six weeks post-implantation: a ﬂuorescent 
light micrograph shows the three weeks alizarin 
layer (A, red) and the ﬁve weeks calcein layer  
(C, green). Bone formation starts in the center 
of the implant and grows to the periphery of the 
implant. Original magniﬁcation 20x.
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Histomorphometry
The results of the measurements are depicted in ﬁgure 6. After one week of 
implantation, bone formation for both the intramuscular and subcutaneous 
group is very limited. At three weeks, the amount of bone formation 
is increased till about 12 percent and stays at this level till six weeks of 
implantation. No signiﬁcant difference between the two groups could be 
observed. Although, the data suggest a decrease in bone formation for the 
intramuscular implants after 6 weeks of implantation, this difference is not 
signiﬁcant.
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Figure 6. Percentage bone formation for each implant type and implantation period as determined 
by histomorphometry. No signiﬁcant difference could be observed between the two groups.
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Calcium content
The results of the measurements are depicted in ﬁgure 7. The data appear to 
indicate a continuous increase in calcium content during the implantation 
period of the constructs in both the subcutaneous as well intramuscular 
recipient sites. Statistical testing revealed that this increase was indeed 
signiﬁcant for the intramuscular implants. Also, the data suggest that 
calcium content at three and six weeks is higher for intramuscular than 
subcutaneous specimens. However, statistical testing revealed that these 
differences were not signiﬁcant. 
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Figure 7. Ca content as a marker for each implant type and implantation period. No signiﬁcant 
difference between the two groups could be observed.
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Discussion
In this experiment we hypothesized that the vascularity of the recipient 
site will have an effect on bone formation in cell-based BGS. Therefore, we 
implanted 48 titanium ﬁber mesh scaffolds, seeded with RBM cells, in a 
subcutaneous and muscle recipient site of rats. Bone formation was assessed 
by histomorphometry and calcium content at one, three and six weeks after 
implantation. 
First, we have to notice that the results of the two analysis methods do 
not completely corroborate. In the calcium content measurements, a 
continuous increase in calcium content was seen during implantation 
time, while in the histomorphometry an increase in bone formation was 
only observed between one and three weeks, with even a tendency to 
decrease at six weeks. Probably, this difference is due to the fact that for 
the histomorphometrical analysis only three sections out of each specimen 
were used in contrast to the calcium assay where the whole specimen 
is used. We know already from other studies, that a wide variation in 
histological observations can occur within the same sample21. Therefore, we 
measure for our histomorphometrical analyses always at least three sections. 
Nevertheless, this can still result in underestimation of the amount of bone 
formation due to lacking data points. On the other hand, overestimation 
can occur in the calcium content analysis, since all calcium as present in 
the sample is measured, which includes the calcium as there is in all cells in 
the scaffold. Therefore, it is essential that the analysis of bone formation is 
always performed by using different methods.
Further, bone formation in our titanium mesh was very limited and hardly 
exceeded 10% of the total construct content. Also, no signiﬁcant differences 
existed between the two recipient sites. Unfortunately this does not 
completely agree with various other reports, since literature suggests that 
muscle is a good donor site in BMP induced ectopic bone formation. 
Apparently, the advantage of blood vessels for oxygen and nutrient delivery 
as well as their associated pericytes as a rich source of stem cells are less 
important when RBM cells are already present in abundance through cell 
seeding. 
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Another factor, which is important in cell-based constructs is the optimal 
time of prolonged culturing after cell seeding in the porous scaffold 
material. In our previous experiment with titanium implants, seeded with 
RBM cells and inserted in a subcutaneous rat model without prolonged 
culturing of the constructs, only a very limited amount of ectopic bone 
formation was found22. In follow-up studies, the optimal time of culturing 
after cell seeding was found to be one day18, 23. Our results conﬁrm these 
results: the consequent rise in calcium content from week one till week six 
for both groups indicates an ongoing process of osteogenic differentiation 
of the marrow stromal cells. Also, the values for the subcutaneous implants 
at six weeks (1231 (± 606) µg/ml) are comparable to the four week results 
of den Dolder (550 (± 200) µg/ml Ca)18. The results of the ﬂuorescence 
microscopy further indicate that bone growth started at the center of the 
titanium mesh and proceeded subsequently during time to the periphery. 
This conﬁrms that the suspension technique is capable of seeding cells not 
only to the surface of the implant, but also deep in the implant. 
Finally, the ultimate goal of our bone engineering experiments is to 
reconstruct large bone defects in human patients. These defects can be 
caused by trauma, tumor or infection. An example of such a defect is a 
resected mandible after tumor surgery. An average mandible of an adult 
male weighs about 80 grams and has a volume of about 60 cm3 24. 
The engineering of such a large bone part will give rise to much more 
vascularity problems during the bone formation, than in the rat model as 
used in this experiment. Besides that, we know that after ablative surgery 
for malignancies, the soft tissues are scarred by surgery and often radiation 
therapy25, 26. This leaves the osteoinductive potential of these tissues 
doubtful. In view of this, bone tissue engineered constructs should be well 
vascularised and the amount of bone should be much more than we can 
currently form. These new reconstructions should be at least as good as 
conventional reconstruction techniques, like the vascularised ﬁbula bone 
graft27. With this conventional technique an adequate volume of bone can 
be made, which is in addition very well vascularised. Comparison with 
the current results, where bone formation is at the most 12%, learns that 
our ﬁnal goal is still very far away. It can even be doubted whether cell-
based constructs are the right way to go. Evidently, more efﬁcient ways of 
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culturing, scaffold materials with bone inductive capacity and probably 
simultaneous use of growth factors, are required to solve the problems.
Conclusion
In summary, our results did not conﬁrm that the vascularity of the recipient 
site plays a signiﬁcant role in the osteoinductive capacity of cell-based 
titanium ﬁber mesh BGS. 
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Introduction 
Much research has been done on Bone Graft Substitutes (BGS). These BGS 
can be fabricated by the interaction of three key components: 1) competent 
bone-forming cells, 2) a suitable framework or scaffold, and 3) the presence 
of biological stimulants1. Treatment of bone defects with growth factors 
alone provides a direct osteoinductive stimulus, but this strategy is still 
dependent upon the presence of osteoprogenitor cells able to respond 
to this signal. Thus, implantation of these exogenous bioactive factors 
may have limited efﬁcacy in clinical scenarios with reduced osteogenic 
potential, such as those involving signiﬁcant bone loss, poor vascularity 
and inadequate soft tissue coverage2. An alternative to the use of growth 
factors is a cell-based approach. An advantage of this approach is that 
in principle immediately sufﬁcient cells with bone forming capacity are 
delivered at the defect site. On the other hand, we know that this cell-based 
approach also faces a lot of problems and challenges3, 4. For example, the 
success of this method depends on multiple factors like the source and 
amount of cells used5, the technique used for culturing6, the environment 
and the scaffold material that is used7. In our laboratory, we try to get a 
better understanding of the effect of all these parameters in cell-based bone 
engineering strategies. For example, in earlier research we investigated the 
osteodifferentiation of marrow stromal cell/scaffold constructs in vitro6, 8, 9. 
Further, we have shown in an ectopic rat model that a titanium ﬁber mesh 
scaffold seeded with rat bone marrow cells produced a limited amount of 
bone. This was independent of the implantation site10, seeding technique11 
and culture method12. Up till now we have mainly used titanium ﬁber mesh 
scaffolds in our studies because of the excellent mechanical properties and 
the bone-compatibility of this material13. On the other hand, we know 
that from a bone point of view calcium phosphate (CaP) ceramic has to 
be preferred above titanium. CaP ceramics are known for their excellent 
osteoconductivity and there are even suggestions that this material is 
osteoinductive14. As a consequence, the aim of the current study is to 
investigate the inﬂuence of the carrier in a cell-based bone regeneration 
approach, whereby we hypothesize that CaP ceramic implants will induce 
more bone formation than titanium ﬁber implants, in the same animal 
model as our previous experiment. To prove this hypothesis, titanium 
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(Ti) ﬁber mesh implants and ceramic implants were seeded with rat bone 
marrow cells (RBM) and implanted subcutaneously. The amount of bone 
formation after one, three and six weeks was evaluated by histology and 
histomorphometry.
 
Materials and methods 
Implants: 
Twenty-four sintered porous Ti-ﬁber mesh implants (Fig. 1a) with a 
volumetric porosity of 86%, density of 600 g/m2 and a ﬁber diameter of 50 
mm were used as scaffold material (Bekaert NV, Zwevegem, Belgium). The 
Ti-ﬁber mesh is fabricated by interengaging and intertwining a multiplicity 
of thin titanium ﬁbers. The ﬁbers are bond at their points of contact using 
a sinter process. This results in a very open interconnected porosity. The 
average pore size of the mesh was about 250 µm. The diameter of the 
implants was 6 mm, the thickness 0.8 mm and the weight about 15 mg. 
Twenty-four control implants consist of a “Biphasic Material” of porous 
Hydroxyapatite (HA) and tricalcium phosphate (TCP) in a relationship of 
60%/40% (CAM implants BV, Leiden, the Netherlands) (Fig. 1b). The pore 
size is 300-500 µm with a volumetric porosity of 75%, The implants have a 
diameter of 6 mm and the height is 3 mm. All specimens were sterilized by 
autoclavation at 121ºC for 15 min. before use.
 
Figure 1a and b. Titanium ﬁber mesh implant with an average pore size of 250 um. The diameter 
of the implants is 6 mm, the thickness 0.8 mm. Figure 1b. “Biphasic Material” of porous 
Hydroxyapatite (HA) and tricalcium phosphate (TCP) in a relationship of 60%/40%. The pore size 
of the material is 300-500 µm2 and the porosity is 75%, the implants have a diameter of 6 mm 
and the height is 3 mm (CAM implants BV).
6 106
Cell culture technique:
The rat bone marrow cell culture technique was used as described by 
Maniatopoulos15. RBM cells were obtained from femora of 16 syngeneic 
male Fisher 344 rats (150-170 g, 6 weeks old). Epiphyses were cut off, 
and both diaphyses were ﬂushed out, using α-Minimal Essential Medium 
(Gibco BRL) supplemented with 10% fetal calf serum (FCS), 50 mg/ml 
freshly prepared ascorbic acid, 10 mM Na-β-glycerophosphate, 10-8M 
dexamethasone and antibiotics. Per two femurs 15 ml of this medium was 
used to generate a cell suspension. This cell suspension was distributed over 
three tissue culture ﬂasks per two femurs. Finally, cultures were incubated in 
a humidiﬁed atmosphere of 95% air and 5% CO2 at 37ºC. 
After 7 days of primary culture (day 0), cells were detached using trypsin/
EDTA and concentrated by centrifugation at 1500 rpm. for ﬁve minutes 
and resuspended in a known amount of medium. A Coulter counter was 
used to count the cells. The cell suspension was diluted to 5 * 106 cells / 
ml in complete media. Subsequently, cells were seeded onto the carrier 
materials. The specimens were loaded by placing the carrier materials in 
a cell suspension of 5 * 106 cells/ml. After a brief exposure to a vacuum 
with a 50 ml syringe, the tubes with the cell suspension and scaffolds were 
placed in an incubator (95% air, 5% CO2, at 37ºC). Every 30 minutes the 
tubes were shaken manually. After 4 hours the scaffolds were removed 
from the suspension and placed in 24 well-plates. Subsequently, 1 ml of 
medium was added to each well. All constructs were cultured for 1 day prior 
to implantation12. Then the medium was replaced by serum-free medium. 
Subsequently, all constructs were transported to the animal facility.
Implantation procedure
For implantation 24 four-week-old syngeneic Fisher 344 male rats were 
used. Surgery was performed under general inhalation anesthesia with 
nitrous oxide and oxygen. The RBM loaded scaffolds were implanted 
subcutaneously into the back of the animals. For the insertion of the 
subcutaneous implants, the animals were immobilized and placed in 
a ventral position. The back of the animals was shaved, washed and 
disinfected with povidone-iodine. Two longitudinal incisions were made on 
both sides of the vertebral column. Lateral of the incisions a subcutaneous 
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pocket was created using blunt dissection. After placement of the implants 
the skin was closed, using Agraven suture material. All titanium implants 
were placed at the left or the right side alternately and the ceramic implant 
was subsequently placed at the contralateral side.. A total of 48 implants 
were placed: 24 Ti implants suspension-loaded with RBM cells (Ti/R-BM) 
and 24 CaP implants suspension-loaded with RBM cells (CaP/R-BM).
Implantation periods were one, three and six weeks. At the end of each 
implantation period eight rats were sacriﬁced (n = 8 for each material and 
time period). 
The animal experiments were performed according guidelines for animal 
experiments for scientiﬁc research of the Dutch government. The used 
animal protocol was approved by the Animal Care Ethics committee of the 
University of Nijmegen.
Evaluation techniques
Histological analysis
Eight specimens of every type and time period were retrieved for 
histological analysis: they were ﬁxed and stored in phosphate-buffered 
4% formalin solution (pH = 7.4). Then, the tissue blocks were dehydrated 
in a graded series of ethanol and embedded in methyl-methacrylate 
(MMA). Subsequently, 10 µm sections of the MMA embedded samples 
were made using a modiﬁed sawing microtome technique16. At least three 
transversal sections of sufﬁcient quality for evaluation were made of each 
implant. The sections were stained with methylene blue and basic fuchsin. 
To evaluate the tissue response to the implants, both histological and 
histomorphometrical analysis was performed. The histological evaluation 
consisted of a complete description of the observed thin sections.
A computer based image analysis system (Qwin Pro, version 2.3, Leica, 
Wetzlar, Germany) was used for histomorphometrical analysis. Two 
parameters were assessed: (1) the surface area of the newly formed bone, 
and (2) the surface area of the titanium respectively CaP ceramic implant. 
In this way the relative bone formation could be measured. All histo-
morphometrical measurements were performed in three different transverse 
sections of each implant, which were averaged to obtain the ﬁnal result.
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Statistical procedure
The histomorphometrical measurements of CaP ceramic and Ti scaffolds 
were statistically evaluated with GraphPad® Instat 3.05 software (GraphPad 
Software Inc, San Diego, CA, USA), using an unpaired T-test with Welch 
correction. To test whether the data were sampled from populations that 
followed Gaussian distributions, the test method of Kolmogorov and 
Smirnov was used.
Results
Clinical observations
All rats showed an undisturbed wound healing without any clinical signs 
of inﬂammation at the surgical sites during the various implantation times. 
At retrieval, the implants were surrounded by a thin reaction-free ﬁbrous 
capsule.
Descriptive light microscopy
One week implants
One week after implantation, all titanium and ceramic implants were 
surrounded by a thin ﬁbrous capsule, which was ﬁve to eight cell layers 
thick. No inﬂammatory reaction was found outside the capsule. Already 
ﬁbrous tissue had penetrated in between the Ti ﬁbers and inside the CaP 
porosity. This ﬁbrous tissue still lacked a clear organization and contained 
only a very low number of inﬂammatory cells. In both the titanium and 
ceramic implants, there was an abundant ingrowth of capillaries. In three 
titanium and seven ceramic implants, bone-like tissue formation was 
observed inside the scaffold porosity. This bone-like tissue had a granular 
appearance and was deposited in small islands. Occasionally, cells were 
observed to be included in the deposited bony matrix. The bone-like islands 
were always surrounded by hypertrophic cartilage-like cells (Fig. 2).
Three week implants
All three week implants were still surrounded by a thin ﬁbrous capsule 
without the presence of inﬂammatory cells. Inside the mesh porosity of 
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Figure 2a and b. After one week in both the titanium group (2a) as well as in the ceramic group 
(2b), the bone islands were always surrounded by hypertrophic cartilage-like cells (both ﬁgures: 
original magniﬁcation 40x). 
Figure 3a and b. After three weeks in both the titanium group (ﬁg. 3a) as well as in the ceramic 
group (ﬁg. 3b), osteocytes could be clearly recognized within the mineralized bone matrix. At 
the periphery of the deposited bone, osteoid and osteoblasts could be seen (both ﬁgures: original 
magniﬁcation 40x).
the titanium and ceramic implants, the ﬁbrous tissue had become more 
organized, as characterized by the clear occurrence of collagen bundles. 
Almost no inﬂammatory cells were seen in the scaffold porosity. Bone 
formation in the scaffold porosity was observed in seven titanium and 
eight ceramic implants. The amount of deposited bone was deﬁnitely 
increased compared with the one week implants, especially for the ceramic 
group. At three weeks, osteocytes could be clearly recognized within the 
mineralized bone matrix both in the titanium group (Fig. 3a) as well in the 
ceramic group (Fig. 3b). At the periphery of the deposited bone, osteoid and 
osteoblasts could be seen. 
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Six week implants
In the six week group, the appearance of the ﬁbrous capsule around the 
titanium and ceramic implants had not changed compared with the three 
week implants. The same was true for the ﬁbrous tissue inside the mesh 
porosity. Bone formation was now observed in seven titanium and eight 
ceramic implants. The appearance of the bone formation differed between 
the titanium and ceramic implants. Bone formation in the titanium mesh 
was observed as a dense entity localized centrally in the implants. The 
bone appeared to grow from the centre to the periphery of the implant in 
the titanium group (Fig. 4a). In contrast, bone formation in the ceramic 
implants occurred through the whole implant. Bone formation was 
characterized by apposition as a shell-like layer on the pore surface with 
subsequent centripetal ﬁll of the pore (Fig. 4b).The deposited bone had 
always further matured compared with the three week specimens. In 
addition, cavities ﬁlled with bone marrow-like tissue were seen within the 
deposited bone in both groups (Fig.5a and b respectively).
Histomorphometry
The results of the measurements are depicted in ﬁgure 6. After 1 week of 
implantation, bone formation for both the titanium and ceramic group is 
very limited. At three weeks, the amount of bone formation is increased 
till about 10 percent for the titanium group and 18 percent for the ceramic 
group. No signiﬁcant difference between the two groups could be observed 
(P>0.05). In the six week group, the bone formation is 6 (Ti) and 23 (CaP) 
percent, respectively. Statistical testing showed that this difference is 
extremely signiﬁcant (P<0.0001). 
Figure 4a and b. After six weeks, in the titanium group bone formation appeared to grow from the 
centre to the periphery of the implant, while no bone formation outside the area of the implant 
was observed. Figure 4b. In the ceramic group bone formation was by apposition of bone to the 
inner surface of the implant (both ﬁgures: original magniﬁcation 2.5x).
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Figure 5a and b. In the titanium group, cavities ﬁlled with bone marrow like tissue were seen within 
the deposited bone. Figure 5b. Cavities ﬁlled with bone marrow tissue could be observed in the 
ceramic group as well (both ﬁgures: original magniﬁcation 40x).
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Figure 6. Percentage bone formation for each implant type and implementation period as 
determined by histomorphometry shows a signiﬁcant difference for the six week group: the 
titanium group shows 6 percent and the ceramic group 23% bone formation.
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Discussion
We hypothesized that the use of a ceramic scaffold in a cell-based BGS 
technique would lead to more bone formation than a titanium ﬁber 
implant. Therefore, we implanted 24 titanium ﬁber mesh implants and 
24 biphasic ceramic implants, seeded with rat bone marrow cells, in a 
subcutaneous recipient site. The amount of bone formation after one, 
three and six weeks was evaluated by histology and histomorphometry. 
Bone formation started earlier in the CaP ceramic scaffolds than in the Ti 
scaffolds (7 vs. 3 positive specimens at one week of implantation). Further, 
after six weeks a signiﬁcant difference in amount of bone formation was 
observed between the titanium and the CaP-ceramic group. The low 
amount of bone formation in the titanium implants corresponds well with 
our earlier studies, in which we found that bone formation hardly exceeded 
ten percent.
As mentioned above, the amount of bone formation in the titanium 
implants was limited, while in the CaP-ceramic group this was much higher. 
In addition, the deposition pattern of the bone in the CaP scaffolds was 
different. Bone formation in the ceramic implants occurred through the 
whole implant and was characterized by apposition as a shell-like layer on 
the pore surface with subsequent centripetal ﬁll of the pore. Consequently, 
the bone in the CaP scaffolds resembles much more trabecular bone. 
In contrast, in the titanium scaffolds the bone appeared to grow from 
the centre to the periphery of the implant. At itself, this is remarkable, 
because due to the diffusion dependent bone formation in porous implants 
growth from the periphery to the centre would be expected. Still, such 
a growth pattern has been described before and is probably caused by 
the fast invasion of our titanium scaffolds with new blood vessels11. The 
observed differences in bone deposition between titanium and CaP-ceramic 
can be explained by the known excellent bone biocompatibility of CaP-
ceramic. In view of this, biphasic CaP ceramics, composed of a mixture 
of hydroxyapatite and tricalcium phosphate, are considered to be even 
more bioactive and more efﬁcient than hydroxyapatite alone17. Combined 
with a BMP (osteogenin), biphasic CaP ceramic, has already shown to 
provide good results in the healing of a segmental defect in a long bone in 
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the rat18. Also, biphasic calcium phosphate ceramics have been shown to 
possess osteoconductive and osteogenic activity in rabbits19. Probably, this 
favorable behavior of CaP-ceramics is the result of the preferential binding 
of growth factors and/or bone marrow cells to CaP-ceramic surfaces20. 
We also know that cell adhesion molecules play an important role in the 
binding of bone forming cells to an implant surface20. Recently, Ripamonti 
et al. even described that sintered hydroxyapatite can spontaneously 
induce bone formation in adult primates without exogenously applied 
BMPs, whereby the implants are thought to adsorb endogenously produced 
osteogenic molecules21. Despite the clear biological advantage of CaP-
ceramic, the weak mechanical properties and the poor resorbability of 
e.g. hydroxyapatite remain a problem for clinical application22. Currently, 
we can only hypothesize that due to the extensive bone formation inside 
the porosity, the biomechanical properties of our CaP scaffolds will be 
completely different from the as received material. In future experiments, 
this hypothesis has to be proven. 
Besides the difference in chemical composition, we have to notice that 
our scaffold materials also differed from each other in pore size and pore 
geometry. It has been shown before that these geometrical parameters can 
affect the amount as well as the pattern of bone growth into the scaffold23-26, 
since they control the diffusion of oxygen, growth factors and nutrients to 
the cells. Although such an effect cannot be excluded completely for our 
Ti-mesh and CaP material, we still do not suppose that these are the driving 
parameters for the observed pattern of bone formation. In a previous study, 
we investigated ectopic bone formation in non-coated and CaP-coated Ti-
mesh in the same animal model27. Histology showed that after 2, 4 and 8 
weeks always more bone was formed in the coated compared to the non-
coated titanium mesh and we concluded already that CaP ceramic can have 
a beneﬁcial effect on the bone-generating properties of a scaffold material. 
Another material that is used as bone graft substitute is demineralized bone 
matrix (DBM). Its bone inductive activity is determined by the amount and 
activity of bone morphogenic proteins (BMP). Bone formation in a DBM 
implant after six weeks has been established before as 25%28, which is about 
the same value as we have found for the ceramic implants. Nevertheless, 
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a disadvantage of DBM compared to cell-based CaP constructs is the 
variability of the osteogenic potential29.
Finally, we have to mention that to improve the bone inductive properties 
of titanium, a surface pretreatment method can be applied30. Such a 
method makes the titanium surface more bioactive and can promote 
cell differentiation. Through chemical and heat treatment, the surface of 
titanium implants is changed to get an appropriate macrostructure and 
microstructure. In this way an apatite layer can form (in vitro as well 
in vivo) onto which bone matrix integrates more easily than just blank 
titanium-oxide.
Conclusion
Our hypothesis that ceramic implants, seeded with rat bone marrow cells 
produce more bone formation than titanium ﬁber implants in the same rat 
model was conﬁrmed. We conclude that the biphasic ceramic implants are 
promising material for bone tissue engineering. Our ﬁndings also support 
the need for further research to assess the efﬁcacy of these materials in 
larger animal models and in orthotopic locations.
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Introduction
The aim in reconstructive surgery is restoration of function and form. 
Reconstructions in head and neck surgery are performed by tissue 
transfer. Local ﬂaps have been used extensively in the past, but they are 
limited in their application. In contrast, microvascular free ﬂaps give the 
opportunity to transfer tissue, which can be tailor-made to the defect 
to be reconstructed. For example, one of the major challenges in head 
and neck reconstructive surgery is the reconstruction of the mandible. 
In this case, the application of microsurgically revascularised bone ﬂaps 
with robust vascularity produces higher success rates than the use of 
non-vascularised bone ﬂaps, especially in irradiated patients1. The most 
often used microsurgical ﬂaps for bone reconstruction are: ﬁbula, iliac 
crest, scapula and radial forearm ﬂap. Unfortunately, such ﬂaps leave the 
patient with inherent donor site morbidity2. Another problem with the 
use of autogenic bone can be a lack of sufﬁcient bone tissue. Therefore, 
the search for other treatment methods with less associated problems has 
to continue. In view of this, recent progress in tissue engineering offers 
perhaps a solution for the current problems with donor site morbidity 
associated with microsurgical ﬂaps, since tissue engineering allows the 
creation of a preshaped, vascularised bone graft at a convenient donor site. 
For this reason, we are carrying out a series of studies with the ultimate 
goal of developing a method for microsurgical reconstruction of bone 
defects with help of a cell-based tissue engineering approach. In our 
strategy, bone marrow is the source for the bone forming cells, which are 
subsequently added to an appropriate carrier or scaffold material. Potential 
carriers, as tested by us, were porous sintered titanium ﬁber mesh and 
porous biphasic calcium phosphate (CaP) ceramic. The titanium mesh 
has excellent mechanical properties in terms of stiffness and elasticity3-6. 
However, an inherent disadvantage of titanium is that it is non-degradable 
and does not further improve bone formation as induced by the bone 
marrow cells. Recently, we found that the porous biphasic CaP ceramic 
appeared to be more suitable7. Bone formation was not only increased in 
this material compared with titanium mesh, but also the distribution of the 
newly formed bone throughout the scaffold as well as the morphological 
appearance was signiﬁcantly better. The next step in our development is to 
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determine the appropriate acceptor site for the ﬁnal microsurgical ﬂap8 and 
to determine how microsurgery affects the bone forming capacity of the 
ﬁnal construct. 
Considering the above mentioned, the present experiment is focused on the 
microsurgical aspect of tissue engineered bone constructs. We implanted 
sixteen porous ceramic implants containing cultured bone marrow cells 
in the adductor thigh muscle ﬂap of the rat. To be sure that the ﬂap relied 
on the vascular pedicle only, just like in a clinical situation, the ﬂap was 
enveloped by a silicone sheet. After four weeks the pedicles of eight ﬂaps 
were cut and directly microsurgically anastomosed. The other eight ﬂaps 
were given a sham operation, in which all branches of the pedicle were 
cut and ligated, but the main pedicle was left intact. Four weeks after the 
second surgery, all implants were harvested and analyzed by histology and 
histomorphometry to study the effect a microvascular operation might 
have on the bone forming process. We hypothesized that the amount 
of bone formation in the microsurgical group would be similar to the 
conventionally pedicled group. 
Materials and methods 
Implants: 
Sixteen implants were used consisting of a “Biphasic Material” of porous 
Hydroxyapatite (HA) and tricalcium phosphate (TCP) in a relationship of 
60%/40% (CAM implants BV, Leiden, the Netherlands) (Figure 1). The pore 
size was 300-500 µm with a volumetric porosity of 75%. The implants had 
a diameter of 6 mm and the height was 3 mm. All specimens were sterilized 
by autoclavation at 121ºC for 15 min. before use.
 
Figure 1. “Biphasic Material” of porous 
Hydroxyapatite (HA) and tricalcium phosphate 
(TCP) in a relationship of 60%/40%. The pore size 
of the material is 300-500 µm, the porosity is 75%, 
the implants have a diameter of 6 mm and the 
height is 3 mm (CAM implants BV).
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Cell culture technique:
The rat bone marrow cell culture technique was used as described by 
Maniatopoulos9. RBM cells were obtained from femora of 12 syngeneic 
male Fisher 344 rats (150-170 g, six weeks old). Epiphyses were cut off, 
and both diaphyses were ﬂushed out, using α-Minimal Essential Medium 
supplemented with 10% fetal calf serum (FCS), 50 mg/ml freshly prepared 
ascorbic acid, 10 mM Na-β-glycerophosphate, 10-8M dexamethasone and 
antibiotics. Per two femurs 15 ml of this medium was used to generate a cell 
suspension. This cell suspension was distributed over three tissue culture 
ﬂasks per two femurs. Finally, cultures were incubated in a humidiﬁed 
atmosphere of 95% air and 5% CO2 at 37
oC. 
After seven days of primary culture (day 0), cells were detached using 
trypsin/EDTA and concentrated by centrifugation at 1500 rpm. for ﬁve 
minutes and resuspended in a known amount of medium. A Coulter 
counter was used to count the cells. The cell suspension was diluted to 
5 * 106 cells/ml in complete media. Subsequently, cells were seeded onto 
the carrier materials. The specimens were loaded by placing the carrier 
materials in a cell suspension of 5 * 106 cells/ml (8 ml cell suspension per 
16 implants). After a brief exposure to a vacuum with a 50 ml syringe, the 
tubes with the cell suspension and implants were placed in an incubator 
(95% air, 5% CO2, at 37ºC). Every 30 minutes the tubes were shaken 
manually. After 4 hours the implants were removed from the suspension 
and placed in 24 well-plates. Subsequently, 1 ml of medium was added to 
each well. All constructs were cultured for 1 day prior to implantation10. 
Then the medium was replaced by serum-free medium. Subsequently, all 
constructs were transported to the animal facility.
Surgical procedure
For implantation eight four-week-old syngeneic Fisher 344 male rats were 
used. Surgery was performed under general inhalation anesthesia with 
nitrous oxide and oxygen. A total of sixteen implants were placed in the 
adductor thigh muscle ﬂap11, two implants were used per rat (Figure 2). 
For the insertion of the implants, the animals were immobilized and 
placed in a supine position. During the implantation procedure the core 
temperature was registered with a rectal probe and maintained with a 
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variable-temperature circulating-water bed. The skin of the animals was 
shaved, washed and disinfected with povidone-iodine. After incising the 
skin on the medial side of the hind limb, the saphenous vessels were 
ligated distally, just above the point where the vessels split in two or three 
branches. The anterior and posterior gracilis muscles were elevated from 
distal to proximal, preserving the branches of the saphenous vessels to 
these muscles. The ﬂap was closed with non-absorbable monoﬁlament 7x0 
sutures (Nylon). Around this muscle ﬂap, a 1.5 x 1.0 cm silicon sheet with 
a thickness of 1.0 mm was wrapped to prevent vascular ingrowth from 
the surrounding tissues. Consequently, the ﬂap was vascularised solely 
from its pedicle. At the end of the operation, the skin was closed with 
stainless steel staples. After four weeks all rats were re-operated: at one side 
the vascular pedicle was cut and microsurgically anastomosed using an 
operation microscope (Zeiss OPMI 6 - DF). After clamping the vessels with 
Ackland microvessel clamps and cutting the artery and the vein of the 
pedicle, the vessels were irrigated with heparin solution and anastomosed 
using Ethilon® 10x0 sutures. At the other side a sham operation was done: 
dissection of the pedicle without cutting the vessels, but with ligation of all 
side branches. Four weeks after the second surgery, all rats were sacriﬁced 
and implants with surrounding tissue retrieved for histological evaluation. 
Figure 2. The implant is placed on the adductor thigh muscle ﬂap. The pedicle of the ﬂap can be 
seen at the right upper side of the ﬁgure. The femoral nerve has been spared and is seen lying 
under the muscle ﬂap. The muscle ﬂap will be folded over the implant and a silicone sheet will 
prevent vascular ingrowth from the surrounding tissues.
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Also, all rats received sequential triple ﬂuorochrome labeling. Fluorochrome 
labels (i.e. tetracycline, alizarin-complexon and calcein (25 mg/kg body 
weight) were administered at week 1, 2 and 3 for the ﬁrst four animals and 
at week 4, 5 and 6 for the second four animals. 
The animal experiments were performed according guidelines for animal 
experiments for scientiﬁc research of the Dutch government. The used 
animal protocol was approved by the Animal Care Ethics committee of the 
University of Nijmegen.
Evaluation techniques
Histological analysis
Four specimens of every type and time period were retrieved for histological 
analysis: they were ﬁxed and stored in phosphate-buffered 4% formalin 
solution (pH = 7.4). Then, the tissue blocks were dehydrated in a 
graded series of ethanol and embedded in methyl-methacrylate (MMA). 
Subsequently, 10 µm sections of the MMA embedded samples were made 
using a modiﬁed sawing microtome technique12. Three transversal sections 
were made of each implant. The sections were stained with methylene 
blue and basic fuchsin to determine bone formation. Additionally, two 
slightly thicker sections (30 mm) were made per implant for analysis with 
a ﬂuorescence microscope. To evaluate the tissue response to the implants, 
both histological and histomorphometrical analysis was performed. The 
histological evaluation consisted of a complete description of the observed 
thin sections. The evaluators were blinded to the treatment groups.
A computer based image analysis system (Qwin Pro, version 2.3, Leica, 
Wetzlar, Germany) was used for histomorphometrical analysis. Two 
parameters were assessed: (1) the surface area of the newly formed bone, 
and (2) the surface area of the ceramic implant. In this way the relative 
bone formation could be measured. All histomorphometrical measurements 
were performed in the three different transverse sections of each implant, 
which were averaged to obtain the ﬁnal result.
Statistical procedure
The histomorphometrical measurements were statistically evaluated with 
GraphPad® Instat 3.05 software (GraphPad Software Inc, San Diego, CA, 
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USA), using an unpaired T-test with Welch correction. To test whether the 
data were sampled from populations that followed Gaussian distributions, 
the test method of Kolmogorov and Smirnov was used.
Results
Clinical observations
After the ﬁrst operation, which consisted of implantation of the ceramic 
implants, all rats showed an undisturbed wound healing without any 
clinical signs of inﬂammation at the surgical sites, except for one side in one 
rat. Here a hematoma developed postoperatively that showed spontaneous 
resorption and did not interfere with the second operation. During the 
second operation at four weeks, in both groups almost no muscle tissue over 
the implants was observed (Figure 3). A striking postoperative observation 
was that all rats, except one, showed a hematoma at the microsurgical side 
but not at the sham operation side. At retrieval, all implants in both groups 
were surrounded by a thin reaction-free ﬁbrous capsule without any sign 
of remaining muscle tissue. Two of the eight microsurgical implants were 
surrounded by a hematoma and one microsurgical implant was surrounded 
by a seroma. No hematomas were observed in the pedicled group. All 
vascular pedicles were patent, as tested by milking the vessels. Some minor 
ingrowth of ﬁbrous tissue along the folds of the silicone envelope to the 
implants was observed.
Figure 3. At explantation, 
no muscle could be 
observed surrounding 
the implants. Instead 
a thin ﬁbrous capsule 
was found. All vascular 
pedicles were patent, as 
tested by milking the 
vessels.
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Descriptive light microscopy
All implants were surrounded by a slightly inﬂamed capsule. No remaining 
muscle tissue from the adductor thigh ﬂap was observed. Also, no vascular 
ingrowth from the surroundings was visible. Bone formation was observed 
in seven out of eight implants in the pedicled group and in all eight 
implants in the microsurgical group. Bone formation in the ceramic 
implants occurred through the whole implant and was characterized 
by apposition as a shell-like layer on the pore surface with subsequent 
centripetal ﬁll of the pore (Figure 4a and 4b). In addition, cavities ﬁlled 
with bone marrow-like tissue were seen within the deposited bone. The 
appearance of the bone was the same in both groups. In one implant of the 
pedicled group, some calciﬁcations outside the original ceramic implant 
and inside the surrounding ﬁbrous capsule were observed (Figure 5).
Fluorescence microscopy
Fluorescence microscopy revealed that formation of bone was characterized 
by apposition as a shell-like layer on the pore surface with subsequent 
centripetal ﬁll of the pore (Figure 6). This observation agrees with previously 
described bone deposition in porous ceramics8,13 and emphasizes the 
osteocompatibility of CaP ceramics.
Figure 4a and b. Bone formation in the ceramic implants occurred through the whole implant. The 
absence of muscle tissue, which was found at explantation, was conﬁrmed histologically. Instead 
a ﬁbrous capsule was observed. Magniﬁcation in 4b.
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Histomorphometry
One implant from the pedicled group did not show any evidence of bone 
formation, all other implants revealed bone formation. Bone formation as 
determined by histomorphometry in the pedicled and the microsurgical 
group is 41 and 38 percent respectively (Figure 7). The standard deviation 
is 18 and 14 percent respectively. There is no signiﬁcant difference between 
both groups (P>0.05).
Figure 5. Calciﬁcations are visible in the 
surrounding ﬁbrous capsule, outside of the 
original implant. The absence of muscle tissue, 
which was found at explantation, was conﬁrmed 
histologically. Instead a ﬁbrous capsule was 
observed.
Figure 6. Fluorochrome markers show bone 
formation from the surface of the implant to the 
center. Alizarine (A) staining at two weeks (red) 
and calcein (C) staining at three weeks (green).
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Figure 7. Bone formation in both the pedicled 
and the revascularised group as determined by 
histomorphometry is about forty percent. The standard 
deviation for the pedicled and the revascularised group 
is eighteen and fourteen percent respectively. There is 
no signiﬁcant difference between both groups.
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Discussion
Currently, we are performing a series of studies with the ultimate goal of 
developing a cell-based tissue engineering technique for the microsurgical 
reconstruction of bone defects. In previous studies, we evaluated already 
the efﬁcacy of scaffold material as well as donor site with respect to the 
bone forming capacity of the construct. In this experiment we have 
explored the inﬂuence of a microvascular transplantation on the construct. 
Histological and histomorphometrical analysis conﬁrmed that cutting 
and anastomosing the vascular pedicles did not inﬂuence the amount 
of bone formation of cell seeded CaP ceramic implants in the adductor 
thigh muscle ﬂap of rats. This corroborates with the ﬁndings of Khouri, 
who demonstrated in a rat model viable bone tissue, eight months after 
prefabrication and microsurgical transplantation of muscle transformed 
into bone by using BMPs14. Similar observations have been reported in a 
minipig model, where viable bone was demonstrated three months after 
microsurgical transplantation of an in this way prefabricated muscle ﬂap15. 
In both studies the vascular pedicle was functional, which is a prerequisite 
for bone formation. Insufﬁcient blood supply reduces bone formation16.  
Our study differed from the aforementioned studies because we induced 
bone marrow cells to induce bone formation instead of BMPs. Also, we 
made a microvascular anastomosis, but did not transplant the prefabricated 
ﬂap to an acceptor site. We wanted to prove ﬁrst the feasibility of our cell-
based technique before entering the next stage of transferring the construct. 
Comparison of the results of our present study with an earlier study in 
which we induced bone formation with similar ceramic implants and 
cultured cells in a subcutaneous pocket, learns that the amount of bone 
formation correlates very well. In the previous study we found 23 percent 
bone formation after six weeks7. In our present study the amount of bone 
formation was 41 and 38 percent after eight weeks. Also the appearance 
of the bone formation between these two studies did not show differences 
either.
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Nevertheless, we have to notice that some problems occurred in the current 
study. One of these is the ﬁnding that in almost all cases a hematoma was 
observed after the microsurgical anastomosis, while no hematoma was seen 
in the control group with the sham operation. In most cases this hematoma 
resorbed spontaneously, but in two rats this hematoma still existed at the 
time of explantation. The exact origin of this hematoma remains unclear. 
Most probably the anastomoses have leaked, especially since no hematoma 
were observed in the sham operated sides. Still, at the time of operation 
the anastomoses were patent and non-leaking, so there must have been 
a secondary leaking after the operation. However, the hematoma did 
not necessarily have a negative inﬂuence on the amount of bone in the 
ﬂap because there was no difference in bone formation between the two 
groups. Evidently, the patency of the pedicle was not hampered due to the 
hematoma because all anastomoses were patent17.
Further, in one of our specimens some small calciﬁcations without 
evidence of osteoblasts were seen outside the implant. Occasionally, so-
called external ectopic bone tissue is observed when superphysiological 
concentrations of exogenous BMP are used18. Evidently, this is not the case 
in our study. We suppose that due to the brittleness of our porous ceramic 
material some particles of the implant had broken off, which caused 
calciﬁcation in the capsule. 
Another comment we have to make is that the muscle ﬂap around 
all implants had completely disappeared, macroscopically as well as 
microscopically. To our knowledge this has not been described before. For 
example, no atrophy of a pedicled adductor muscle was seen three weeks 
after implantation of a coral scaffold combined with type I collagen and 
BMP-2 in the gracilis muscle of rats19. Also, a pedicled latissimus dorsi 
muscle ﬂap was still maintained three weeks after bone formation by 
wrapping this muscle around just a collagen carrier with BMP-220. In cases 
when only a bony reconstruction is needed, this loss of muscle tissue is 
no disadvantage when no bulky soft tissue is desired. Besides, we have to 
notice that a microsurgical reconstruction is even now possible because the 
vascular pedicle, which has been supplied by the muscle is still functioning. 
In other cases where a composite reconstruction is needed, other tissue like 
skin can be used, by including it in the prefabrication process.
Finally, we noticed some ingrowth of ﬁbrous tissue along folds of the 
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silicone rubber envelope. The occurrence of such an ingrowth was not 
described before in another study where also the muscle was isolated form 
the surrounding tissue21. We suppose that this ingrowth did not inﬂuence 
the bone formation inside our specimens, because we could not detect 
vascular ingrowth from the surroundings into the ceramic scaffold in the 
histological slices. 
Conclusion
Our results show that in rats viable microsurgical bone ﬂaps can be 
obtained by using a cell-based tissue engineering approach. The amount of 
bone formation in a pedicled ﬂap and in a microsurgical ﬂap did not differ 
signiﬁcantly in porous CaP ceramic scaffolds provided with bone marrow 
cells. These results warrant the further pursuit of this method in order to 
solve the problems associated with conventional microsurgical free ﬂaps. 
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Summary and address to the aims
Microvascular osteocutaneous free ﬂaps have given reconstructive surgeons 
a powerful tool in the treatment of large defects involving hard and soft 
tissues in head and neck surgery. For example, radial forearm, scapula, 
iliac crest and ﬁbula ﬂaps have been used extensively in mandibular 
reconstruction. The inevitable donor site morbidity of these osteocutaneous 
ﬂaps has received less attention than the reconstructive advantages. In 
chapter one, a review of the literature is presented for each type of ﬂap 
to determine the kind, incidence and consequences of ﬂap associated 
morbidity. In the future tissue-engineered prefabricated free ﬂaps might 
play an important role to solve this morbidity problem. In view of this, 
the objective of this thesis is to develop a method for the microsurgical 
reconstruction of bone defects based on a tissue engineering approach. 
Using this technique, cultured bone marrow cells can be seeded in an 
appropriate carrier or scaffold in a suitable site. This so called prefabricated 
ﬂap can then be transplanted with microsurgical techniques to a defect, 
e.g. a segmental mandibular gap. In the subsequent chapters of this thesis, 
the aims as described in chapter one of this thesis will be addressed. Each 
subsequent chapter comprises a separate investigation.
Aims
1. Can MRI be used in a longitudinal study to noninvasively detect 
bone formation in a rat model and can it give quantitative as well as 
morphological information about the construct? 
In animal studies on tissue engineering of bone, histology remains the 
standard for assessing bone formation. As longitudinal studies with this 
method are feasible only at the cost of large numbers of animals, we 
looked for an alternative. Therefore, demineralized bone matrix (DBM) 
and inactivated demineralized bone matrix (iDBM) implants were 
subcutaneously implanted in a rat. At 1, 3, 5, and 7 weeks postimplantation 
soft X-ray and magnetic resonance imaging (MRI) were done to monitor 
bone formation in the implants. At 7 weeks, the animal was killed and the 
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implants were retrieved for histology. The results showed that in vivo MRI 
is well suited to assess bone formation larger than 0.5 mm in diameter and 
to monitor the complete three-dimensional shape of the newly formed 
bone in a noninvasive manner in this longitudinal study. The MRI results 
matched well with the histology results as obtained at 7 weeks. In contrast, 
X-ray imaging appeared inappropriate to monitor the bone formation 
process in DBM.
2. What is the best method for noninvasive monitoring of bone formation, 
MRI or DEXA? And can MRA be used to demonstrate the vascularity of the 
pedicle of a prefabricated ﬂap?
The aim of the study was to further explore the utilization of Magnetic 
Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA) and 
Dual-Energy X-ray Absorptiometry (DEXA) to assess bone formation and 
blood circulation in a pedicled bone graft substitute. In 14 Wistar rats, 
initially ten weeks old, heterogeneous demineralized femur bone matrix 
implants were wrapped in pedicled adductor thigh muscle ﬂaps. One rat 
died after surgery. Subsequently, bone formation and maintenance of blood 
ﬂow was evaluated in six rats after six weeks of implantation by means of in 
vivo MRI/MRA and post-mortem histomorphometry. The other seven rats 
were left for 12 weeks, after which bone formation was evaluated by in vivo 
DEXA and post-mortem histomorphometry.
The results demonstrated that after six weeks bone formation was present 
in four out of six animals, quantiﬁed as 42% (± 35%) and 25% (± 19%) by 
means of MRI and histomorphometry respectively. MRA was able to show 
patency of the pedicles of these four rats only, which suggests that the lack 
of blood supply in the other two rats was the cause of failure to form bone. 
In the 12 week group, histology showed increased bone formation without 
signs of osteolysis, which was quantiﬁed histomorphometrically to be as 
high as 48% (± 15%). DEXA failed to show bone formation. 
It is concluded that in vivo MRI proved to be a reliable method for 
monitoring ectopic bone formation in a rat model, while in vivo DEXA 
was unable to detect the implants. Furthermore, in vivo MRA proved to be 
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a very useful technique for studying the circulation of muscle ﬂaps in this 
animal model.
3. What is the inﬂuence of the surface area of the carrier for the bone 
forming capacity?
Demineralized bone matrix (DBM) has been shown to induce ectopic 
endochondral bone formation, when intramuscularly implanted in rats. 
In chapter two and three we have found a variation in bone formation 
capacity of this DBM. This might be due to the properties of the DBM itself, 
but the use of DBM blocks could be of inﬂuence as well. Therefore, this 
study was designed to investigate whether increasing the surface area of the 
DBM by morsellizing, inﬂuences the bone formation capacity. In view of 
this, DBM implants and morsellized DBM (MDBM) implants were placed 
intramuscularly in a rat model. At six weeks the implants were retrieved and 
evaluated by histology and histomorphometry. The results demonstrated 
that signiﬁcant amounts of newly formed bone were present in some DBM 
as well as some MDBM implants while in others no, or very little new bone 
was found. Histomorphometric analysis showed an average bone formation 
of 2.6% in DBM implants and an average of 1.9% in MDBM implants. Still, 
the amount of bone formation was limited compared with previous studies. 
It is concluded that enlargement of the surface area by morsellizing DBM 
implants is not an important factor in bone forming capacity.
4. What is the most useful carrier for a cell-based construct, titanium ﬁbre 
mesh or a ceramic implant?
Much research has been done to develop the ideal bone graft substitute 
(BGS). One approach to develop this ideal BGS is the use of growth 
factors, but for this approach osteoprogenitor cells are needed at the site 
of reconstruction. An alternative is a cell-based approach, where enough 
cells are provided to form bone in a carrier material. In previous studies of 
our group, titanium (Ti) carriers have been used, because of the excellent 
mechanical properties and the bone-compatibility of this material. On 
the other hand, calcium phosphate (CaP) ceramics are known for their 
excellent osteoconductivity. The aim of this study is to investigate the 
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inﬂuence of the carrier in a cell-based bone regeneration approach, 
whereby we hypothesize that CaP ceramic implants will induce more 
bone formation than Ti-ﬁber implants, in the same animal model as our 
previous experiment. Ti-ﬁber mesh implants and ceramic implants were 
seeded with rat bone marrow cells (RBM) and implanted subcutaneously. 
Histological analysis after one, three and six weeks showed differences 
in the way of bone formation in the two groups: bone appeared to grow 
from the centre to the periphery of the implant in the titanium group, 
while bone formation in the ceramic group occurred through the whole 
implant. Histomorphometrical analysis after one week showed very limited 
bone formation for both the titanium and ceramic group. At three weeks, 
the amount of bone formation was increased till about 10 percent for 
the titanium group and 18 percent for the ceramic group. No signiﬁcant 
difference between the two groups could be observed. In the six week 
group, the bone formation was 6 (Ti) and 23 (CaP) percent, respectively 
(P<0.0001). Further, bone formation started earlier in the CaP ceramic 
scaffolds than in the Ti scaffolds. Our hypothesis could be conﬁrmed: 
ceramic implants induce more bone formation than titanium implants. 
5. What is the most useful acceptor site for a prefabricated ﬂap, muscle or 
subcutaneous tissue?
Bone Graft Substitutes (BGS) can be fabricated by the combination of three 
key ingredients: 1) competent bone-forming cells, 2) a suitable framework 
or scaffold, and 3) the presence of biological stimulants. Although much 
research has been done to develop the ideal BGS, the results are still not 
very consistent. In view of this, the cellularity and vascularity of the 
recipient site are supposed to be important for the osteoinductive capacity 
of BGS. Therefore, we hypothesized that a muscle recipient site could favor 
bone formation in a cell-based BGS compared to a subcutaneous recipient 
site due to the higher vascularity of muscle tissue. To prove this hypothesis, 
48 titanium (Ti) ﬁber mesh implants were seeded with rat bone marrow 
stromal cells (RBM) and implanted subcutaneously and intramuscularly 
in the adductor thigh muscle of rats. The amount of bone formation after 
one, three and six weeks was evaluated by histology and histomorphometry 
as well as by calcium content. Analysis revealed that bone formation 
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increased during implantation. However, bone formation did not exceed 
above 12 percent of the implant surface, both for the intramuscular and 
subcutaneous recipient site. Also, no signiﬁcant differences in bone amount 
between these two sites existed. Consequently, our hypothesis could not be 
conﬁrmed. 
6. What is the inﬂuence of a microsurgical anastomosis of the vascular 
pedicle of a prefabricated muscle ﬂap on the tissue engineered bone in this 
ﬂap?
We have conducted a series of studies with the ultimate goal of developing 
a method for microsurgical reconstruction of bone defects with the 
help of tissue engineering techniques. In this study we determined how 
microsurgery affects the bone forming capacity of the ﬁnal construct. 
Therefore we implanted 16 ceramic implants with cultured cells in the 
adductor thigh muscle ﬂap of the rat, which was enveloped by a silicone 
sheet. After four weeks the pedicles of eight ﬂaps were cut and directly 
microsurgically anastomosed. The other eight ﬂaps were given a sham 
operation, in which all branches of the pedicle were cut and ligated, but 
the main pedicle was left intact. Four weeks after the second surgery, all 
implants were harvested and analyzed by histology and histomorphometry. 
The histological appearance of the bone was found to be similar in both 
groups. Histomorphometry did not reveal statistical signiﬁcant differences 
in bone formation. We conclude that in a rat model viable microsurgical 
bone ﬂaps can be obtained by using a cell-based tissue engineering 
approach.
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Closing remarks and future perspectives
In this thesis, we have described the development of a method for 
microsurgical reconstruction of bone defects with the help of tissue 
engineering techniques. We have created a model of a prefabricated bone 
in a pedicled muscle ﬂap, which was revascularised. The ultimate goal of 
reconstructing a mandible in a human being has yet to be achieved. First 
of all, the next step should be the use of a larger animal model like a goat, 
to study mandibular reconstruction1, 2. In larger animals, new challenges 
will arise. Nevertheless, the effectiveness of the combination of cell-based 
scaffolds and prefabrication has always to be proven in higher animals, 
before its application in humans. In this context, the combination of 
growth factors and cells with a carrier might be advantageous compared 
to the use of growth factors or cells alone. For example, it can allow a 
decrease in the concentration of these growth factors that have to be used 
to induce bone formation. Further, it can also solve the problems with 
the ﬁnal yield of osteogenic cells that can be derived out of bone marrow. 
Considering growth factors and cells, perhaps an even more promising 
method is the implantation of genetically modiﬁed cells. This combines cell 
transplantation and delivery of osteogenic factors at the same time and has 
already been shown to increase the effectiveness of both approaches3.
The current investigation revealed that further research is required to 
achieve the ﬁnal goal, i.e. the manufacturing of preshaped tissue engineered 
bone ﬂaps. This will undoubtedly imply major investments both ﬁnancially 
and in terms of man power. However, we also experienced that the actual 
clinical applicability is still in its infancy4. Although the community could 
put questions to the enormous costs versus the small beneﬁts of tissue 
engineering, this thesis showed that tissue engineering is in potency an 
important development in health care. In the future it will certainly be 
possible to reconstruct osseous defects in various parts of the human body 
with these techniques.
 
8 140
8 141
References
1  Fennis, J. P., Stoelinga P. J. and Jansen J. A. Mandibular reconstruction: a clinical and 
radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma  
Int J Oral Maxillofac Surg. 31: 281, 2002.
2  Fennis, J. P., Stoelinga P. J. and Jansen J. A. Mandibular reconstruction: a histological and 
histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous 
bone grafts and platelet rich plasma in goats Int J Oral Maxillofac Surg. 33: 48, 2004.
3  Blum, J. S., Barry M. A. and Mikos A. G. Bone regeneration through transplantation of 
genetically modiﬁed cells Clin Plast Surg. 30: 611, 2003.
4  Lysaght, M. J. and Hazlehurst A. L. Tissue engineering: the end of the beginning Tissue Eng. 
10: 309, 2004.
8 142
8 143
hoofdstuk acht  
Samenvatting, evaluatie van de 
doelstellingen, afsluitende opmerkingen  
en toekomstperspectief
 
 
 
8 144
Samenvatting en evaluatie van de doelstellingen
Door de ontwikkeling van microvasculaire osteocutane lappen hebben 
reconstructief chirurgen een belangrijk wapen in handen gekregen bij het 
herstel van complexe hoofd-halsdefecten. Zowel de radialis onderarmslap, 
als de scapula-lap, crista iliaca-lap en ﬁbula-lap worden frequent gebruikt 
voor het herstel van de mandibula. De reconstructieve voordelen van 
deze osteocutane lappen hebben in de literatuur meer aandacht gekregen 
dan de onvermijdelijke donorplaatsmorbiditeit. In hoofdstuk één wordt 
voor bovengenoemde lappen een overzicht van de beschikbare literatuur 
gegeven, waarbij aard, incidentie en consequenties van deze lap-gerelateerde 
morbiditeit wordt behandeld. In de toekomst kunnen zogenaamde 
‘tissue engineered’ geprefabriceerde lappen een belangrijke rol spelen 
bij het oplossen van dit morbiditeitsprobleem. Het doel van de studie 
ten grondslag liggend aan dit proefschrift is dan ook om een methode te 
ontwikkelen voor de microchirurgische reconstructie van botdefecten, 
gebaseerd op tissue engineering technieken. Gebruik makend van deze 
technieken, kunnen gekweekte beenmergcellen gezaaid worden in een 
geschikt dragermateriaal. Vervolgens kan dit als implantaat in een geschikte 
plaats in het lichaam ingebracht worden. Nadat er voldoende botvorming 
is opgetreden in dit implantaat, kan deze zogeheten geprefabriceerde 
lap met behulp van microchirurgische technieken verplaatst worden 
naar een botdefect, zoals dat bijvoorbeeld is ontstaan na een segmentale 
mandibularesectie. In de opeenvolgende hoofdstukken van dit proefschrift, 
zullen de doelen, die in hoofdstuk één van dit proefschrift zijn gesteld, 
behandeld worden. Elk hoofdstuk is gebaseerd op een separaat onderzoek.
Vraagstellingen
1. kan MRI gebruikt worden om op een non-invasieve wijze botvorming 
in een ratmodel in tijd te volgen en kan op deze wijze quantitatieve en 
morfologische informatie verkregen worden over het gevormde bot?
Histologisch onderzoek is de gouden standaard voor evaluatie van 
botvorming in proefdierexperimenten. Dit maakt dat longitudinale 
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studies alleen uitgevoerd kunnen worden door gebruik te maken van grote 
aantallen dieren. Daarom is gezocht naar een alternatieve methode om 
botvorming te bepalen. Hiertoe werden implantaten van gedemineraliseerde 
botmatrix (DBM) en geïnactiveerde gedemineraliseerde botmatrix (iDMB) 
subcutaan bij een rat ingebracht. Om de botvorming te volgen werden 
op één, drie, vijf en zeven weken na implantatie röntgenfoto’s gemaakt 
en werden MRI (magnetische resonantie imaging) opnames gemaakt. Na 
zeven weken werd de rat gedood en werden de implantaten uitgenomen 
voor histologisch onderzoek. Onze resultaten laten zien dat in-vivo MRI 
uitstekend botvorming met een minimale afmeting van 0,5 mm kan 
aantonen. Met behulp van deze techniek kan ook de driedimensionale 
vorm van het nieuw gevormde bot gereconstrueerd worden. Tevens kan de 
botvorming in de tijd vervolgd worden. De resultaten van de MRI komen 
ook goed overeen met de histologische resultaten die na zeven weken 
werden verkregen. In tegenstelling hiermee, bleken de röntgenologische 
afbeeldingen niet geschikt om het proces van botvorming in DBM te 
volgen.
2. wat is de beste niet-invasieve methode om botvorming te volgen, MRI of 
Dual-Energy X-ray Absorptiometry (DEXA)? Kan magnetische resonantie 
angiograﬁe (MRA) gebruikt worden om de doorbloeding van de vaatsteel 
van een geprefabriceerde lap aan te tonen?
Het doel van deze studie was om verder onderzoek te doen naar het gebruik 
van MRI, MRA en DEXA om de botvorming en de bloedvoorziening van 
een gesteeld bottransplantaatsubstituut te beoordelen. In 14 Wistar ratten 
werden heterologe gedemineraliseerde botimplantaten in een gesteelde 
adductordijspierlap gewikkeld. Eén rat stierf direct na de operatie. Van 
zes ratten werd botvorming en functie van de bloedvaten na zes weken 
geëvalueerd middels in-vivo MRI/MRA en post-mortem histologisch 
en histomorfometrisch onderzoek. Van de overige zeven ratten werd 
botvorming na 12 weken bepaald middels in-vivo DEXA en post-mortem 
histologisch en histomorfometrisch onderzoek.
Na zes weken was er botvorming opgetreden bij vier van de zes dieren. 
De gemiddelde botvorming gemeten met MRI en histomorfometrie was 
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respectievelijk 42% (±35%) en 25% (±19%). MRA-onderzoek toonde alleen 
bij deze vier dieren een intacte vaatsteel aan. Dit suggereert dat het verlies 
van de bloedvoorziening bij de andere twee dieren de oorzaak is van het 
niet optreden van botvorming. Histologisch onderzoek na 12 weken liet 
zien dat er meer botvorming was opgetreden, zonder tekenen van osteolyse. 
De histomorfometrisch bepaalde gemiddelde botvorming was 48% (±15%). 
Met behulp van DEXA kon deze botvorming niet aangetoond worden.
De conclusie luidt dat in-vivo MRI een betrouwbare methode is om 
ectopische botvorming aan te tonen in een ratmodel. DEXA daarentegen 
kan niet gebruikt worden om de implantaten aan te tonen. Verder blijkt 
in-vivo MRA een zeer bruikbare techniek om de bloedvoorziening van 
spierlappen in dit diermodel te bestuderen.
3. wat is de invloed van de grootte van het oppervlak van het 
dragermateriaal voor de botvormende capaciteit?
Als gedemineraliseerde botmatrix (DBM) intramusculair in ratten wordt 
geïmplanteerd, wordt ectopische botvorming geïnduceerd. In hoofdstuk twee 
en drie is beschreven dat de botinducerende capaciteit van verschillende 
DBM-implantaten sterk verschilt. Dit wordt mogelijk veroorzaakt door 
de eigenschappen van het DBM zelf. De vorm waarin het DBM gebruikt 
wordt, als één implantaat of in kleinere fragmenten, zou hierbij een rol 
kunnen spelen. Daarom werd in deze studie onderzocht of de vorm waarin 
DBM wordt geïmplanteerd inderdaad de botvormende capaciteit van DBM 
beïnvloedt. Zowel DBM implantaten uit één stuk, als DBM implantaten die 
uit kleinere fragmenten bestonden (MDBM), werden intramusculair in een 
ratmodel geïmplanteerd. Na zes weken werden de implantaten uitgenomen en 
werd de botvorming geëvalueerd middels histologisch en histomorfometrisch 
onderzoek. In enkele DBM- en enkele MDBM-implantaten werden signiﬁcante 
hoeveelheden nieuw gevormd bot aangetoond, terwijl in andere implantaten 
geen of zeer weinig bot werd aangetroffen. Histomorfometrische analyse liet 
een gemiddelde botvorming van 2,6% zien voor de DBM-implantaten en 
een gemiddelde van 1,9% voor de MDBM-implantaten. Deze hoeveelheid 
botvorming was minder dan in voorgaande studies. Geconcludeerd wordt dat 
vergroting van het oppervlak door het fragmenteren van DBM-implantaten 
geen belangrijke factor is in de botinducerende capaciteit.
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4. wat is de meest geschikte drager voor een construct, dat gebaseerd is op 
het gebruik van cellen?
Er is veel onderzoek gedaan om het ideale bottransplantaat(BGS) te 
ontwikkelen. Een benadering om dit ideale bottransplantaatsubstituut te 
ontwikkelen is door middel van het gebruik van groeifactoren. Hiervoor 
is het nodig dat er osteoprogenitorcellen aanwezig zijn op de plaats van 
reconstructie. Een alternatief voor deze methode is het gebruik van cellen. 
De cellen worden in een dragermateriaal geladen en vervolgens wordt het 
geheel in lichaamsweefsel geïmplanteerd. In voorgaande studies van onze 
groep is voor deze celtechniek gekozen, waarbij titanium (Ti) werd gebruikt 
als dragermateriaal. Titanium werd gekozen in verband met de uitstekende 
mechanische eigenschappen van dit materiaal en de compatibiliteit van 
titanium met bot. In plaats van titanium zou ook gebruik gemaakt kunnen 
worden van een keramiek als calciumfosfaat (CaP). Dit materiaal staat 
met name bekend om zijn uitstekende osteoconductieve eigenschappen. 
Het doel van deze studie was om de invloed van het dragermateriaal te 
bestuderen voor een op cellen gebaseerde benadering van botregeneratie. 
De hypothese was dat poreuze calciumfosfaat dragers meer botvorming 
induceren dan titaniumvezelgaas implantaten. Titanium vezelgaas 
en CaP implantaten, gezaaid met gekweekte beenmergcellen (RBM), 
werden subcutaan geïmplanteerd in ratten. Histologische analyse na een 
implantatieperiode van één, drie en zes weken laat zien dat de manier 
waarop de botvorming plaatsvond in deze twee materialen verschilt: in de 
titaniumgroep bleek botvorming op te treden vanuit het centrum naar de 
periferie van het implantaat, terwijl de botvorming in de keramiekgroep 
uniform door het hele implantaat plaatsvond. Histomorfometrische analyse 
liet verder zien dat na één week zeer weinig botvorming optrad in zowel 
de titaniumgroep als de CaP groep. Na drie weken was de hoeveelheid 
botvorming toegenomen tot 10 procent voor de titanium groep en tot 18 
procent voor de CaP groep. Na zes weken was er signiﬁcant (P<0,0001) 
meer bot gevormd in de CaP groep (23%), dan in de titanium groep (6%). 
De hypothese dat poreuze CaP dragers meer botvorming induceren dan 
titanium vezelgaas werd dan ook bevestigd.
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5. wat is de optimale acceptor site voor een geprefabriceerde lap?
Bottransplantaatsubstituten kunnen verkregen worden door de combinatie 
van drie bestanddelen: 1) botvormende cellen, 2) een geschikte drager, en 
3) de aanwezigheid van biologische groeifactoren. Hoewel veel onderzoek 
is verricht om het ideale bottransplantaatsubstituut te ontwikkelen, zijn 
de resultaten nog niet erg consistent. De aanwezigheid van cellen en de 
doorbloeding van de receptorplaats worden als belangrijke factoren gezien 
voor de botinductieve eigenschappen van een bottransplantaatsubstituut. 
De hypothese is dat in een op cellen gebaseerd bottransplantaatsubstituut 
meer botvorming optreedt in spierweefsel, dan in subcutaan weefsel, omdat 
spierweefsel een betere doorbloeding heeft dan subcutaan weefsel. Om 
deze hypothese te bewijzen werden beenmergcellen (RBM) gezaaid op 48 
titaniumvezelgaasimplantaten, waarna deze implantaten zowel subcutaan 
als intramusculair in de adductordijbeenspier van ratten werden geplaatst. 
De hoeveelheid botvorming na één, drie en zes weken werd geëvalueerd 
middels histologisch en histomorfometrisch onderzoek, alsook door het 
calciumgehalte in de dragermaterialen te bepalen. De resultaten lieten zien 
dat de botvorming toenam gedurende de implantatietijd. Echter, zowel in 
de intramusculaire groep als in de subcutane groep bleef de botvorming 
beperkt tot 12 procent. Tussen de twee locaties kon geen signiﬁcant verschil 
in botvorming aangetoond worden. Derhalve kon onze hypothese niet 
bevestigd worden.
6. wat is de invloed van een microchirurgische anastomose op bot, dat met 
behulp van tissue engineering technieken in een geprefabriceerde spierlap is 
verkregen?
Het uiteindelijke doel van deze studies is om een methode te ontwikkelen 
voor microchirurgische reconstructie van botdefecten met behulp van 
tissue engineering technieken. In de onderhavige studie is gekeken naar 
de invloed van het microchirurgisch anastomoseren van de vaatsteel 
van een geprefabriceerde spierlap op de botvormende capaciteit van het 
uiteindelijke bottransplantaatsubstituut. Daartoe werden 16 poreuze CaP 
keramische implantaten, geladen met beenmergcellen, aangebracht in de 
adductordijbeenspierlap van ratten. De spierlappen werden omwikkeld met 
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een siliconen membraan om vaatingroei uit de omgeving te voorkomen. Na 
vier weken werd de vaatsteel van acht lappen doorgenomen en direct hierna 
microchirurgisch hersteld. De andere acht lappen kregen een controle 
operatie, waarbij alle zijtakken van de vaatsteel werden geligeerd, maar 
waarbij de vaatsteel zelf niet werd doorgenomen. Vier weken na de tweede 
operatie werden alle implantaten uitgenomen en geanalyseerd met behulp 
van histologisch en histomorfometrisch onderzoek. In alle implantaten 
werd vitaal botweefsel waargenomen. Histomorfometrisch onderzoek 
liet geen statisch signiﬁcante verschillen in hoeveelheid botvorming 
zien. Daarom luidt de conclusie dat in een ratmodel levensvatbare 
microchirurgische botlappen verkregen kunnen worden door gebruik te 
maken van een op cellen gebaseerde tissue engineering benadering.
Afsluitende opmerkingen en toekomstperspectief
In dit proefschrift is de ontwikkeling beschreven van een methode voor 
de microchirurgische reconstructie van botdefecten met behulp van tissue 
engineering technieken. Er is een model gecreëerd van geprefabriceerd bot 
in een gesteelde en gerevasculariseerde spierlap in ratten. Het uiteindelijke 
doel om een mandibula te reconstrueren in de mens, moet nog worden 
bereikt. Hiertoe zal nog meer onderzoek moeten worden verricht. Een 
eerste stap zal het gebruik van een groter proefdier, zoals bijvoorbeeld de 
geit1, 2 zijn. In grotere dieren zullen andere omstandigheden voorkomen, 
die nieuwe vraagstellingen zullen opleveren. Echter alvorens de methode 
toepassing te laten vinden in mensen, zal de effectiviteit van de combinatie 
van op cellen gebaseerde dragers en prefabricage altijd eerst bewezen 
moeten worden in hogere dieren,. In dit kader dient opgemerkt te worden 
dat de combinatie van groeifactoren en cellen met een drager voordelen kan 
hebben ten opzichte van het gebruik van uitsluitend groeifactoren of cellen. 
Op deze wijze zou bijvoorbeeld de concentratie van groeifactoren, die 
gebruikt dient te worden om botvorming te induceren, verminderd kunnen 
worden. Verder zou wellicht ook het probleem van de hoeveelheid cellen 
die uit beenmerg geoogst moet worden om botvorming te bewerkstelligen, 
opgelost kunnen worden. Dit zal een tweede stap zijn in het komend 
onderzoek. Ten aanzien van groeifactoren en cellen, zou implantatie van 
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genetisch gemodiﬁceerde cellen nog veelbelovender kunnen zijn. Hiermee 
worden op hetzelfde moment cellen getransplanteerd en osteogene factoren 
aangeleverd. Er is al aangetoond dat deze methode de effectiviteit van 
beide benaderingen verhoogt3. Dit zal een derde stap zijn in het komend 
onderzoek.
Het gedane onderzoek heeft geleerd dat er een grote investering in tijd en 
geld nodig is om het uiteindelijke doel, te weten het vervaardigen van door 
tissue engineering verkregen voorgevormde bottransplantaten, te bereiken. 
Wij hebben ook ervaren dat de huidige klinische toepasbaarheid van tissue 
engineering nog in zijn kinderschoenen staat4. Hoewel de gemeenschap 
vragen kan stellen bij de enorme kosten afgezet tegen de op het moment 
nog geringe voordelen van tissue engineering, laat dit proefschrift zien 
dat tissue engineering in potentie een belangrijke ontwikkeling in de 
gezondheidszorg is. In de toekomst zal het zeker mogelijk zijn om met deze 
technieken botdefecten op diverse plaatsen in het menselijk lichaam te 
reconstrueren. 
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Dankwoord
Het is al zo vaak gezegd, dat het een cliché lijkt: promoveren doe je niet 
alleen. Dat het geen cliché is, dat heb ik inmiddels aan den lijve mogen 
ervaren. Veel mensen hebben direct of indirect meegewerkt aan de 
totstandkoming van dit proefschrift. Ik wil iedereen hiervoor hartelijk 
danken.
Prof. dr. J.A. Jansen. Beste John, onder jouw inspirerende leiding is dit 
onderzoek tot een goed eind gekomen. Ik heb veel respect voor jou als 
persoon en hoe je jouw afdeling in korte tijd op zo´n hoog internationaal 
niveau hebt gebracht. Ik ben er van overtuigd dat de samenwerking tussen 
onze beide afdelingen nog veel onderzoek en vele promoties op gaat leveren. 
Daarnaast zullen wij ook onze minder formele contacten ongetwijfeld blijven 
onderhouden.
Prof. dr. P.H.M. Spauwen. Beste Paul, nadat je een belangrijk deel van mijn 
opleiding voor je rekening hebt genomen, heb je mij de kans gegeven 
om mijzelf als staﬂid te proﬁleren. Jij had er vertrouwen in dat ik zou 
promoveren, en dat blijkt niet onterecht. Dank voor je vertrouwen, je 
aanmoedigingen en geduld: het heeft resultaat gehad! Ik hoop dat we ons 
gezamenlijk nog vele jaren kunnen inzetten voor de afdeling.
Dr. J.M.H.M. Borghouts. Beste Hans, als opleider heb jij mij destijds de kans 
gegeven om plastisch chirurg te worden, hartelijk dank daarvoor. Om Julien 
van Rappard aan te halen: ”zonder opleiding wordt het nooit wat …”. Het 
doet me deugd dat ik je verzuchting `Ed, die promoveert nooit´ nu kan 
weerspreken.
Dr. J.W.M. Vehof. Beste Johan, samen zijn we het avontuur begonnen. 
Bedankt voor je hulp en ondersteuning bij dit proefschrift. Ik ben er trots 
op dat je een fraai proefschrift hebt geschreven en dat je nu je opleiding tot 
plastisch chirurg in het UMCN aan het afronden bent. Ik denk dat we beiden 
een goede keuze gemaakt hebben, destijds ... Ik ben benieuwd hoe je toekomst 
er uit gaat zien: kies je voor een academische loopbaan of ligt je toekomst in 
de periferie?
Drs. P.Q. Ruhé. Beste Quinten, als ‘opvolger van Johan’ heb je het uitstekend 
gedaan. Ook jij bedankt voor je hulp en ondersteuning bij dit proefschrift. 
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Ons tissue engineering congres in Orlando en de paar uur in Miami zal ik niet 
snel vergeten. Ik hoop je ook snel op onze afdeling terug te zien als plastisch 
chirurg in opleiding, en wie weet …
Dr. J.A. Pikkemaat. Beste Jeroen, ik herinner me de uren die we samen hebben 
doorgebracht in de krochten van het Centraal Dierenlaboratorium (waar 
de MRI-apparatuur staat opgesteld) en de vele correcties van de eerste twee 
hoofdstukken, die we elkaar via de e-mail heen en weer stuurden. Hartelijk 
dank voor deze vruchtbare samenwerking. Ongetwijfeld komen we elkaar 
weer tegen in de Vereeniging tijdens een fraai concert.
Drs C.C. Schouten. Beste Corinne, de eerste stap heb je al gezet: je eerste 
artikel is geaccepteerd voor publicatie en staat in dit proefschrift. Ik zal je 
carrière in de plastische chirurgie met belangstelling en vertrouwen volgen.
Ik wil ook bedanken: Jacques van Asten en prof. dr. Arend Heerschap voor 
de hulp bij het MRI-onderzoek, prof. dr. Wim Oyen voor de ondersteuning 
bij het onderzoek met de DEXA-scan, drs. Yu Lan Khouw voor een deel van 
de operaties voor hoofdstuk 3; Elise van Haalen voor ondersteuning bij 
de operaties op het dierenlab, drs. (hoe lang nog?) Henriëtte Deutman dr. 
Juliëtte den Dolder en drs. Esther Bodde voor hun aandeel in de inspirerende 
promotiebesprekingen.
De medewerkers van het laboratorium biomaterialen wil ik met nadruk 
noemen: Anja de Ruijter, dank voor je hulp bij de celkweken en je verdere 
steun en medeleven: het was altijd prettig om met je van gedachten te 
wisselen; Jan-Paul van der Waerden dank voor het vele werk achter de 
computer voor de histomorfometrie en de fraaie prints; ik denk met genoegen 
terug aan onze discussies over automatisering en netwerken; Jacky den Bakker, 
dank voor het vele zaagwerk van de coupes. Dr. Joop Wolke, bedankt voor je 
hulp met de implantaten en de siliconen sheets, het was ﬁjn om naast het 
wetenschappelijke werk ook even over andere onderwerpen van gedachten te 
kunnen wisselen.
De medewerkers op het Centraal Dierenlaboratorium mogen uiteraard ook 
niet ongenoemd blijven: Debbie Smits, Geert Poelen, Kai Poelen, Theo van 
den Ing en Alex Hanssen. Jullie gaven me altijd het gevoel welkom te zijn en 
jullie hulp was altijd professioneel.
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Eddy Kopp en Philip van Damme wil ik hierbij alvast bedanken voor het feit 
dat zij mij als paranimf op mijn promotiedag terzijde zullen staan. Eddy, na 
vele jaren van vriendschap hoop ik dat je deze keer op tijd weet te komen ... 
Philip, nog hartelijk dank voor je ondersteuning in moeilijke promotietijden 
… En als je ooit nog eens zonder auto komt te staan …
Ik dank staf, assistenten en secretariaat van de afdeling plastische chirurgie 
van het Universitair Medisch Centrum Nijmegen (UMCN) evenals OK-
assistenten en verplegend personeel op de poli en de verpleegafdelingen N20 
en B21/22 voor de genoeglijke samenwerking. Graag wil ik alle anderen in 
het UMCN bedanken voor de vaak jarenlange samenwerking: de chirurgische 
specialismen, de anaesthesiologie, maar ook het management waar ik veel 
mee heb samengewerkt. Peter van der Linden verdient een extra Pluim, 
voor de langjarige samenwerking die uiteindelijk in een ziekenhuisbrede 
implementatie van een fraai operatieplanning- en registratiesysteem (Okapi) 
heeft geresulteerd.
Een speciale band heb ik met alle teamleden van onze humanitaire missies 
voor Interplast Holland en de Nederlandse Nomastichting: het ‘hug team’ is 
in de annalen bijgeschreven. We gaan zeker weer terug naar Afrika!
De lagere school is een belangrijke stap op weg naar een wetenschappelijke 
loopbaan, maar dit wordt nogal eens onderschat. Ik wil met name de 
‘meesters’ Vermolen en Kremers bedanken: zij hebben destijds de kiem gelegd 
en deden dat op hun eigen bijzondere wijze.
Mijn ouders en zusjes wil ik bedanken voor de liefdevolle interesse, die zij 
gedurende al die jaren hebben getoond. Emil Gunsing, bedankt voor je 
vriendschap, al meer dan 45 jaar lang! Eddie Hagen is zeer belangrijk geweest 
voor mijn vorming, maar helaas veel te vroeg uit mijn leven verdwenen: ‘uit 
de tijd gevallen’. 
Tot slot, maar niet in de laatste plaats, wil ik Marlies bedanken: liefste 
Marlies, zonder jouw steun had ik het niet gered, en dat geldt niet alleen 
voor dit proefschrift. Ik ben er trots op dat je mijn levensgezellin bent en ik 
hoop dat je nog vele malen ‘een jaartje bijtekent’.
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volgen van de lagere school in Mijdrecht. In 1977 start hij met de studie 
Geneeskunde aan de Vrije Universiteit te Amsterdam. Tijdens deze studie 
woont hij een microchirurgische reconstructie bij, die door Frits Groeneveld 
en Reinier Schoorl in Beverwijk wordt uitgevoerd. Dit is een openbaring: 
“microchirurgie, dat wil ik!” Na het artsexamen in 1985, volgt een jaar 
postdoctorale Medische Informatica met als onderwerp ‘expert systemen’. 
Deze studie wordt omgezet in de vooropleiding Algemene Heelkunde in 
het Sint Joannes de Deo Ziekenhuis te Haarlem bij dr. B.W. van Neerijnen, 
waarin de vaatchirurgie onder leiding van Johan Coosemans bijzondere 
aandacht krijgt. In 1990 wordt de vervolgopleiding Plastische Chirurgie in 
het Academisch Ziekenhuis Nijmegen gestart bij dr. J.M.H.M. Borghouts.
Na afronding van de opleiding wordt de relatie met Nijmegen niet 
verbroken: bewust wordt gekozen voor werken in een academisch 
ziekenhuis. Speerpunten zijn de microchirurgische reconstructies en de 
schisis. Voor het optimaliseren van microchirurgische facialisreconstructies 
wordt prof. dr. Ronald Zuker in Toronto bezocht, terwijl voor de perforator 
ﬂaps prof. dr. Fu Chen Wei in Taiwan wordt bezocht.
Daarnaast worden managementtaken ontwikkeld: reeds jaren is hij 
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hoofd van de afdeling.
Uiteraard betekent een academische carrière ook participatie in het 
studentenonderwijs en de opleiding van plastisch chirurgen: sinds 2003 is 
hij ofﬁcieel plaatsvervangend opleider in de Plastische Chirurgie.
In 2004 wordt het redacteurschap van het European Journal of Plastic and 
Reconstructive Surgery verworven.
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Plastic Surgery Workshop.
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en Orlando (2003, Tissue Engineering Society International).
Onder de vlag van Interplast Holland en de Nederlandse Noma Stichting 
voert hij regelmatig humanitaire missies uit in Afrika en het Midden 
Oosten.
Marlies van Melick is zijn levensgezellin, samen wonen zij in de stad 
Nijmegen.
9 157
Curriculum vitae
Ed Hartman – born on February 6th in Amsterdam – followed elementary 
school in Mijdrecht and he graduates from high school and college 
(gymnasium) in Amstelveen at the Keizer Karel College. In 1977 he starts 
medical school at the Free University in Amsterdam. During this study, a 
microvascular reconstruction performed by Frits Groeneveld and Reinier 
Schoorl in Beverwijk is a revelation: “microsurgery, that’s what I want!” 
After ﬁnishing his medical studies in 1985, he starts one year of Medical 
Information Science with as main subject ‘expert systems’. This study is 
stopped in order to start his general surgery residency with dr. B.W. van 
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Zuker in Toronto for his microsurgical facial reanimations, and prof. dr. Fu 
Chen Wei in Taiwan for his perforator ﬂaps.
Management becomes important: he becomes interim chef de clinique and 
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students and residents: in 2003 he becomes Assistant Professor.
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Reconstructive Surgery.
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